,Rank,NCTId,Condition,BriefTitle,InterventionName,OfficialTitle,LocationCity,LocationState,LocationCountry,StartDate
0,1,NCT01589549,Acute GVH Disease,Mesenchymal Stromal Cells for Acute Graft Versus Host Disease,Mesenchymal stromal cell therapy,A Phase 2 Trial of Standard of Care Treatment Versus Mesenchymal Stromal Cell Therapy Together With Standard of Care for the Treatment of de Novo Acute Graft Versus Host Disease Following Allogeneic Bone Marrow Transplantation,Perth,Western Australia,Australia,April 2012
1,2,NCT02387151,Rejection|Graft Loss,Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients,mesenchymal stromal cells,Safety of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients,Leiden,,Netherlands,March 2015
2,3,NCT03509870,Diabetic Foot Ulcer,Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds,mesenchymal stromal cells,Uncontrolled Non-randomised Single Dose Study of Topically Applied Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells (REDDSTAR (ORBCEL-M)) in Patients With Non-healing Neuroischaemic Diabetic Foot Wounds',Gentofte,,Denmark,"June 1, 2018"
3,4,NCT04447833,"ARDS, Human|COVID",Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,Mesenchymal Stromal Stem Cells - KI-MSC-PL-205,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome Validation of Mechanistic Pathways and Clinical Efficacy,Uppsala,,Sweden,"June 17, 2020"
4,5,NCT02057965,Renal Transplant Rejection|Fibrosis,Mesenchymal Stromal Cell Therapy in Renal Recipients,Mesenchymal Stromal Cells,Autologous Bone Marrow Derived Mesenchymal Stromal Cell Therapy in Combination With Everolimus to Preserve Renal Structure and Function in Renal Recipients,Leiden,,Netherlands,March 2014
5,6,NCT01090817,Crohn Disease,An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease,Mesenchymal stromal cells (MSC) for infusion,A Multicentre Australian Phase 2 Study to Evaluate Safety and Efficacy of Mesenchymal Stromal Cells for Treating Biologic Refractory Crohn's Disease,Perth,Western Australia,Australia,January 2010
6,7,NCT01522716,Graft-Versus-Host Disease,Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease,Mesenchymal stromal cells,Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease,Stockholm,,Sweden,August 2011
7,8,NCT02097641,"Respiratory Distress Syndrome, Adult",Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START),Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells|Plasma-Lyte A,"Prospective, Randomized, Multi-center Phase 2 Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome (ARDS)",San Francisco|Stanford|Boston|Saint Paul|Columbus|Pittsburgh,California|California|Massachusetts|Minnesota|Ohio|Pennsylvania,United States|United States|United States|United States|United States|United States,"March 15, 2014"
8,9,NCT02150551,Inflammatory Bowel Diseases,Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease,Allogeneic bone marrow-derived mesenchymal stromal cells,Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease,Washington,District of Columbia,United States,September 2015
9,10,NCT02012153,Kidney Transplant Rejection,Mesenchymal Stromal Cells in Kidney Transplant Recipients,Mesenchymal Stromal Cells,Autologous Mesenchymal Stromal Cells to Induce Tolerance in Living-donor Kidney Transplant Recipients,Bergamo,,Italy,December 2013
10,11,NCT03042572,Peripheral Arterial Disease|Cardiovascular Diseases|Vascular Diseases,Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs,Allogeneic Mesenchymal Stromal Cell|Placebo,"Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs; A Double-blind, Randomized, Placebo-controlled Trial",Utrecht,,Netherlands,December 2018
11,12,NCT03818854,"Respiratory Distress Syndrome, Adult",Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome,Human Mesenchymal Stromal Cells|Cell Reconstitution Media,"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) for the Treatment of Acute Respiratory Distress Syndrome",Sacramento|San Francisco|San Francisco|Portland|Nashville|Houston|Seattle,California|California|California|Oregon|Tennessee|Texas|Washington,United States|United States|United States|United States|United States|United States|United States,"November 26, 2019"
12,13,NCT02323789,Recessive Dystrophic Epidermolysis Bullosa,Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa,Mesenchymal stromal cells,A Phase I/II Study Evaluating Allogeneic Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa,London,,United Kingdom,June 2015
13,14,NCT02032446,Hematologic Malignancies,Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease,UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC),UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) FOR THE TREATMENT OF SEVERE (GRADE III-IV) STEROID-RESISTANT GRAFT VERSUS HOST DISEASE (GvHD): A PHASE I/II TRIAL,Bergamo|Cuneo|Firenze|Genova|Milano|Monza|Udine|Vicenza,,Italy|Italy|Italy|Italy|Italy|Italy|Italy|Italy,September 2013
14,15,NCT03461458,Degenerative Disc Disease,"Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease",Autologous Adipose-Derived Mesenchymal Stromal Cells,"A Phase I Study Evaluating the Safety and Feasibility of Autologous, Culture-Expanded Adipose-Derived Mesenchymal Stromal Cells in Subjects With Painful Degenerative Disc Disease",Rochester,Minnesota,United States,"October 17, 2018"
15,16,NCT03478215,Renal Transplantation|Mesenchymal Stem Cells,Mesenchymal Stromal Cells in Living Donor Kidney Transplantation,Mesenchymal Stromal Stem Cells (MSCs) Infusion|Normal Saline (Placebo) Infusion,"A Double-blind, Randomized, Controlled Dose Escalation Trial of Autologuous Mesenchymal Stromal Cells in Living Donor Kidney Transplant Recipients",Houston,Texas,United States,December 2016
16,17,NCT05286255,COVID-19 Pneumonia|Viral Pneumonia,Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias,Allogeneic Mesenchymal Stromal Cells,"Safety and Tolerability of Allogeneic Umbilical Cord Derived Mesenchymal Stromal Cells (UC-MSCs) to Limit COVID Associated ComplicatioNs: An Open Label, Phase 1 Study in Hospitalized Patients (SAMPSON-1)",Charleston,South Carolina,United States,"May 4, 2022"
17,18,NCT00644410,Congestive Heart Failure,Autologous Mesenchymal Stromal Cell Therapy in Heart Failure,Mesenchymal stromal cell|Saline,"A Single Centre, Randomised Controlled Study of the Effect of NOGA-guided Direct Intramyocardial Injection of Mesenchymal Stromal Cells on the Development of New Myocardium and Blood Vessels in Patients With Heart Failure",Copenhagen,,Denmark,September 2008
18,19,NCT03268603,ALS|Amyotrophic Lateral Sclerosis,Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS),Autologous Adipose-derived Mesenchymal Stromal Cells,A Phase II Study of Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis,Scottsdale|Jacksonville|Rochester,Arizona|Florida|Minnesota,United States|United States|United States,"October 10, 2017"
19,20,NCT01061099,Osteogenesis Imperfecta Type II|Osteogenesis Imperfecta Type III,Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta,Mesenchymal Stromal Cells,A Pilot Study to Assess the Safety and Feasibility of Repeated Infusions of Mesenchymal Stromal Cells (MSC) in Children With Osteogenesis Imperfecta,Philadelphia,Pennsylvania,United States,February 2010
20,21,NCT01764100,Graft vs Host Disease,Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD),Mesenchymal stromal cells,Mesenchymal Stromal Cells (MSC) for the Treatment of Severe (Grade II-IV) Steroid-resistant Graft Versus Host Disease (GVHD): a Phase I Trial,Bergamo|Monza|Monza,BG|MB|MB,Italy|Italy|Italy,September 2009
21,22,NCT02215811,"Acute Respiratory Distress Syndrome, Adult",Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells,Mesenchymal stromal cells,Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells,Stockholm|Uppsala,,Sweden|Sweden,March 2014
22,23,NCT02291770,Chronic Graft-Versus-Host Disease,Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells,Mesenchymal Stromal Cells,Treatment of of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells. A Phase III Randomized Open Label Multi-center Study in Southern China.,Guangzhou,Guangdong,China,October 2014
23,24,NCT04445454,Coronavirus Infection,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,Mesenchymal stromal cells,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,Li√®ge,,Belgium,"June 12, 2020"
24,25,NCT02814864,Pelvic Radiation Therapy|Radiation-induced Hemorrhagic Cystitis,"Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",Mesenchymal Stromal Cell (MSC) injections,"Clinical Phase II Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",Paris,,France,"April 14, 2021"
25,26,NCT03211793,Systemic Sclerosis|Digital Ulcer,Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis,Mesenchymal stromal cells|Placebo,Mesenchymal Stromal Cells for Angiogenesis and Neovascularisation in Digital Ulcers of Systemic Sclerosis: the MANUS Trial,Utrecht,,Netherlands,"October 6, 2021"
26,27,NCT02805855,"Osteoarthritis, Knee",Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis,Autologous Adipose-Derived Mesenchymal Stromal Cells,Safety and Feasibility of Autologous Culture Expanded Adipose Derived Mesenchymal Stromal Cells in the Treatment of Painful Knee Osteoarthritis,Rochester,Minnesota,United States,"October 26, 2016"
27,28,NCT04626583,Mesenchymal Stromal Cells|Cornea|Safety|Corneal Defect,Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells,Allogeneic MSC,Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells for Promoting Corneal Repair,Chicago,Illinois,United States,"March 5, 2021"
28,29,NCT04466098,Acute Respiratory Distress Syndrome|ARDS (Moderate or Severe)|COVID-19 Pneumonia,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),Mesenchymal stromal cells|Placebo,"Multi-center, Randomized, Placebo Controlled, Interventional Phase 2A Clinical Trial Evaluating the Safety and Potential Efficacy of Multiple Dosing of Mesenchymal Stromal Cells in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2)",Minneapolis|Pittsburgh,Minnesota|Pennsylvania,United States|United States,"July 30, 2020"
29,30,NCT03233074,Myelodysplastic Syndromes|Acute Myeloid Leukemia|Cardio-vascular Surgery,Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors,Bone marrow analyses,Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS),Saint-Priest-en-Jarez|Saint-√âtienne,,France|France,"November 17, 2017"
30,31,NCT04345601,Sars-CoV2|Acute Respiratory Distress Syndrome|COVID-19,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),Mesenchymal Stromal Cells|Supportive Care,"Single Donor Banked Bone Marrow Mesenchymal Stromal Cells for the Treatment of COVID-19 Induced ARDS: A Non-Blinded Randomized, Controlled Study",Houston,Texas,United States,"February 12, 2021"
31,32,NCT01038596,Osteoarthritis,Mesenchymal Stromal Cells and Osteoarthritis,,Proliferation and Osteogenic Differentiation of Bone Marrow-derived Mesenchymal Stromal Cells From Osteoarthritic Versus Healthy Donors,Dresden,,Germany,January 2009
32,33,NCT04356287,"Sclerosis, Systemic|Mesenchymal Stem Cells",Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis,UCMSC|Placebo,Phase I/II Randomized Controlled Trial of Umbilical Cord-derived mesenChymAl stRomal cElls in Systemic Sclerosis,,,,November 2022
33,34,NCT04549285,Multisystem Inflammatory Syndrome in Children,Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome,Human Cord Tissue Mesenchymal Stromal Cells (hCT-MSCs),A Phase I Pilot Study of the Safety of Infusions of Allogeneic Human Cord Tissue Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome in Children (MIS-C),Atlanta|Westchester|Durham,Georgia|New York|North Carolina,United States|United States|United States,"March 12, 2021"
34,35,NCT04348461,COVID|Respiratory Distress Syndrome,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,"Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19",Madrid,,Spain,"May 6, 2020"
35,36,NCT03608631,KRAS NP_004976.2:p.G12D|Metastatic Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8,iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation,Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA,Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation,Houston,Texas,United States,"January 27, 2021"
36,37,NCT03014219,Perianal Fistula,Phase 1 Crohn's Pediatric Sub-study of MSC AFP,Only 1 arm: treatment with MSC-AFP,A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study,Rochester,Minnesota,United States,July 2017
37,38,NCT04236479,Congenital Heart Disease (CHD),Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP),BM-MSC,Mesenchymal Stromal Cells Delivery Through Cardiopulmonary Bypass in Pediatric Cardiac Surgery,Washington,District of Columbia,United States,"July 29, 2020"
38,39,NCT01659762,Crohn's Disease,A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.,autologous mesenchymal stromal cell,A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stromal (MSC) Cells in Adults With Moderate to Severe Crohn's Disease.,Atlanta,Georgia,United States,July 2012
39,40,NCT02646007,Kienb√∂ck's Disease,Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease,BM-MSC transplantation,Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation for Human Avascular Necrosis of the Lunate Bone of the Wrist (Kienbock's Disease),Tehran,,"Iran, Islamic Republic of",November 2015
40,41,NCT04255147,Bronchopulmonary Dysplasia,Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia,Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells,Helping Underdeveloped Lungs With Cells (HULC): Mesenchymal Stromal Cells in Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia - Phase 1 Study,Ottawa,Ontario,Canada,June 2022
41,42,NCT02580695,Osteoarthritis,A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis,umbilical-cord mesenchymal stromal cells|Hyaluronic Acid,"A Phase I/II, Randomized, Double-blind, Controlled Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UC-MSCs) in Patients With Knee Osteoarthritis",Santiago,,Chile,December 2015
42,43,NCT01175655,Bronchiolitis Obliterans|Lung Transplantation,A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation,MSC,A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation,Brisbane|Perth,Queensland|Western Australia,Australia|Australia,February 2010
43,44,NCT02565459,Chronic Renal Failure,MSC and Kidney Transplant Tolerance (Phase A),Mesenchymal Stromal Cells,Third-party Bone Marrow-derived Mesenchymal Stromal Cells to Induce Tolerance in Recipients of Kidney Transplants From Deceased Donors (Phase A),Bergamo,,Italy,September 2015
44,45,NCT05061030,Type1diabetes,Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents,the ATMP Protrans,"A Double-blinded, Randomized, Parallel, Placebo-controlled Trial of Wharton's Jelly-derived Allogeneic Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents",Uppsala,,Sweden,"January 14, 2022"
45,46,NCT03973827,Type1diabetes,Wharton¬¥s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes,ProTrans,"An Open Label, Parallel Single Center Trial of Wharton's Jelly Derived Allogeneic Mesenchymal Stromal Cells Repeatedly Treated to Preserve Endogenous Insulin Production in Adult Patients Diagnosed With Type 1 Diabetes",Huddinge,,Sweden,"May 17, 2019"
46,47,NCT00957931,Sickle Cell Disease|Thalassemia|Diamond-Blackfan Anemia,"Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs",Bone marrow transplantation|Mesenchymal Stromal Cells,"Pilot Study MUD HCT:Pts High Risk Sickle Cell,Other Non-Malignant RBC Disorders- Reduced Intensity Preparative Regimen, HAPLO-Identical Mesenchymal Stromal Cells",Birmingham|Minneapolis,Alabama|Minnesota,United States|United States,March 2009
47,48,NCT03917797,"Lupus Erythematosus, Systemic|Lupus Glomerulonephritis",Mesenchymal Stromal Cells (MSC¬¥s) in Renal Lupus,MSC treatment|Standard of Care|Placebo,Dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Renal Systemic Lupus Erythematosus,Santiago de Chile|Santiago de Chile,Regi√≥n Metropolitana|Regi√≥n Metropolitana,Chile|Chile,"April 2, 2019"
48,49,NCT04467047,COVID-19|Sars-CoV2,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,Mesenchymal Stromal Cells infusion,Safety and Feasibility of Allogenic Mesenchymal Stromal Cells in the Treatment of COVID-19,,,,"July 25, 2020"
49,50,NCT04615429,Acute Respiratory Distress Syndrome|COVID-19 Pneumonia,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,Mesenchymal stromal cells|Placebo,"Double-blind, Randomized, Controlled, Clinical Trial to Assess the Efficacy of Allogenic Mesenchymal Stromal Cells in Patients With Acute Respiratory Distress Syndrome Due to COVID-19",Majadahonda,Madrid,Spain,"September 15, 2020"
50,51,NCT01872624,Pulmonary Emphysema,Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema,Bronchoscopy,Bone-marrow Derived Mesenchymal Stromal Cells Associated With One-way Endobronchial Valves in Patients With Pulmonary Emphysema: Safety Study,Curitiba|Rio de Janeiro|Porto Alegre,PR|RJ|RS,Brazil|Brazil|Brazil,May 2013
51,52,NCT02421484,Septic Shock,Cellular Immunotherapy for Septic Shock: A Phase I Trial,Allogeneic mesenchymal stromal cells,Cellular Immunotherapy for Septic Shock: A Phase I Trial,Ottawa,Ontario,Canada,May 2015
52,53,NCT04328714,Acute Leukemia|Myelodysplastic Syndromes,Interferon Œ≥-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease,Interferon gamma (IFNŒ≥)-primed human bone marrow-derived mesenchymal stromal cells,Interferon Œ≥-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease After Allogeneic Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies and Myelodysplasia,Atlanta|Atlanta|Atlanta,Georgia|Georgia|Georgia,United States|United States|United States,"December 2, 2021"
53,54,NCT01742260,Surgically-Created Resection Cavity,Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials,Repair of cranial defects by tissue engineering,A Pilot Study to Demonstrate Safety and Feasibility of Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials,Perth,Western Australia,Australia,July 2013
54,55,NCT05035862,Asthma,Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma,Albuterol Sulfate|Interferon gamma-primed mesenchymal stromal cells (MSCs)|Prednisone,"A Phase 1 Study to Evaluate Safety, Toxicity, and Potential Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma",Atlanta,Georgia,United States,"March 16, 2022"
55,56,NCT02230514,Atrophic Nonunion of Fracture,Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones,XCEL-MT-OSTEO-ALPHA|autologous iliac crest|Surgery,"A Phase IIa, Single Center, Prospective, Randomized, Parallel, Two-arms, Single-dose, Open-label With Blinded Assessor Pilot Clinical Trial to Assess ex Vivo Expanded Adult Autologous Mesenchymal Stromal Cells Fixed in Allogeneic Bone Tissue (XCEL-MT-OSTEO-ALPHA) in Non Hypertrophic Pseudoarthrosis of Long Bones",Sant Cugat,Barcelona,Spain,"November 20, 2014"
56,57,NCT05559801,Osteogenesis Imperfecta|Osteogenesis Imperfecta Type III,Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI),Bone marrow-derived mesenchymal stromal cells (MSCs),A Phase 1/2 Study to Examine the Safety and Preliminary Efficacy of Mesenchymal Stromal Cells on Linear Growth and Bone Health Parameters in Children With Type 3 Osteogenesis Imperfecta (OI),,,,October 2022
57,58,NCT04361942,COVID-19 Pneumonia,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),Mesenchymal Stromal Cells|Placebo,"Double Blind, Placebo-controlled, Phase II Trial to Evaluate Safety and Efficacy of Allogenic Mesenchymal Stromal Cells MSV_allo for Treatment of Acute Respiratory Failure in Patients With COVID-19 Pneumonia (COVID_MSV)",Valladolid,,Spain,"May 1, 2020"
58,59,NCT02260375,Liver Transplant Rejection,MSC Therapy in Liver Transplantation,Mesenchymal Stromal Cells,THIRD-PARTY BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS TO INDUCE TOLERANCE IN LIVER TRANSPLANT RECIPIENTS,Bergamo|Bergamo|Bergamo|Bergamo|Bologna|Bologna,,Italy|Italy|Italy|Italy|Italy|Italy,October 2014
59,60,NCT02495766,Relapsing-Remitting Multiple Sclerosis|Secondary Progressive Multiple Sclerosis,Autologous Mesenchymal Stromal Cells for Multiple Sclerosis,XCEL-MC-ALPHA|Placebo,Treatment of Autologous Mesenchymal Stem Cells Derived From Bone Marrow as a Potential Therapeutic Strategy for the Treatment of Multiple Sclerosis,Barcelona,,Spain,"May 11, 2015"
60,61,NCT02384018,Chronic Pancreatitis|Diabetes,Mesenchymal Stem Cell and Islet Co-transplantation,autologous mesenchymal stromal cell,A Phase I Study Evaluating Safety and Tolerability of Autologous Bone Marrow-derived Mesenchymal Stromal Cells in Chronic Pancreatitis Patients Who Undergo Total Pancreatectomy and Islet Autotransplantation.,Charleston,South Carolina,United States,December 2014
61,62,NCT03298399,Sickle Cell Disease,Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease,Autologous MSCs|Autologous MSCs|Autologous MSCs,A Phase I Study of Mesenchymal Stromal Cells to Promote Stem Cell Engraftment in Patients With Severe Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation,,,,"December 21, 2017"
62,63,NCT02943486,"Foot Ulcer, Diabetic",Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2,dac-MSCs|MSCs|Fitostimoline,Mesenchymal Stromal Cell Derivatives: a New Alternative and Potential Product for the Treatment of Diabetic Foot Ulcers 1 and 2,,,,January 2017
63,64,NCT04089579,Autism|Autism Spectrum Disorder,hCT-MSC in Children With Autism Spectrum Disorder,Cord Tissue Mesenchymal Stromal Cells|Placebo Infusion,"A Phase II Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder",Durham,North Carolina,United States,"October 12, 2020"
64,65,NCT05204329,Mesenchymal Stromal Cells|Cornea|Corneal Defect|Corneal Epithelium Defect,Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease,MSC Secretome Eye Drops,Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease,,,,"December 1, 2022"
65,66,NCT03449069,Fistula in Ano|Crohn Disease,Pediatric MSC-AFP Sub-study for Crohn's Fistula,MSC-AFP,A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study,Rochester,Minnesota,United States,"July 23, 2018"
66,67,NCT04918706,Pulmonary Emphysema|Mesenchymal Stromal Cells,Allogeneic MSC Treatment for Pulmonary Emphysema,Allogeneic MSC|Placebo,An Explorative Study for Halting Inflammation in Patients With Emphysema by Administration of Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells.,Leiden,,Netherlands,"June 25, 2019"
67,68,NCT02807389,Surgical Leak Fistula,Stem Cell Fistula Plug in Post Surgical Leak Fistulas,MSC Fistula Plug,A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Complicated Post-surgical Fistulas,Rochester,Minnesota,United States,"March 14, 2017"
68,69,NCT02589119,Perianal Fistula|Cryptoglandular Perianal Fistula,Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP),MSC-AFP,"A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With High, Transsphincteric Cryptoglandular Perianal Fistulas",Rochester,Minnesota,United States,January 2016
69,70,NCT03220243,Fistula Vagina|Crohn Disease,Stem Cell Coated Fistula Plug in Patients With Crohn's RVF,MSC-AFP,A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Rectovaginal Fistulizing Crohn's Disease,Rochester,Minnesota,United States,"October 19, 2017"
70,71,NCT01849237,Septic Shock|Nonchemotherapy Drug-induced Neutropenia|Neutropenia After Chemotherapy in Oncohematological Patients|Neutropenia in Patients With Aplastic Anemia,Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia,Mesenchymal stromal cells|Standard therapy of septic shock,Russian Single-center Open Randomized Clinical Trial of the Impact of Mesenchymal Stromal Cells Therapy on Organ Dysfunction and 28-day Mortality in Patients With Septic Shock and Severe Neutropenia.,Moscow,,Russian Federation,December 2012
71,72,NCT02359929,Graft Versus Host Disease|Acute Graft Versus Host Disease|Chronic Graft Versus Host Disease,BMT Autologous MSCs for GvHD,Autologous mesenchymal stromal cells (MSCs),A Phase I Study of Mesenchymal Stromal Cells for the Treatment of Acute and Chronic Graft Versus Host Disease,Atlanta,Georgia,United States,January 2015
72,73,NCT04714801,Lung Transplant Rejection,Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation,adipose derived mesenchymal stromal cells|Saline,"A Danish, Single Centre, Double-blind, Randomized Study Evaluating Allogeneic Adipose Tissue Derived Mesenchymal Stromal Cell Therapy to Reduce Primary Graft Dysfunction After Lung Transplantation",Copenhagen,,Denmark,"October 1, 2020"
73,74,NCT01306513,Emphysema,Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema,autologous bone marrow derived mesenchymal stromal cells,Effect of Autologous Bone Marrow Derived Mesenchymal Stromal Cells Prior to Lung Volume Reduction Surgery for Severe Pulmonary Emphysema- a Phase I Safety and Feasibility Study,Leiden,,Netherlands,October 2010
74,75,NCT04034316,Nephrotic Syndrome in Children|Steroid-Dependent Nephrotic Syndrome|Idiopathic Nephrotic Syndrome,Reduce Immunosuppression With Atmp in NS ChildrEn,Cord-blood mesenchymal stromal cells,A Phase 2 Open-label Study to Evaluate the Efficacy of Allogeneic Human Cord Blood-derived Mesenchymal Stromal Cells in Maintaining Remission After Immunosuppressive Therapy Withdrawal in Pediatric Patients With Steroid-dependent Nephrotic Syndrome,Milan,MI,Italy,"November 2, 2018"
75,76,NCT04675359,Knee Osteoarthritis|Chondropathy,Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment,Autologous adipose derived Mesenchymal Stromal Cells (MSC) injection into the knee joint,Comparison of the Treatment Results of Knee Osteoarthritis Using Adipose Tissue Mesenchymal Stromal Cells Derived Through Enzymatic Digestion and Mechanically Fragmented Adipose Tissue,,,,"July 1, 2021"
76,77,NCT01449032,Chronic Ischemic Heart Disease,MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial),MSC|Saline,MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial),Copenhagen,,Denmark,April 2010
77,78,NCT04333368,Severe Acute Respiratory Syndrome Coronavirus 2|Severe Acute Respiratory Distress Syndrome,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,Umbilical cord Wharton's jelly-derived human|NaCl 0.9%,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,Paris|Paris,,France|France,"April 6, 2020"
78,79,NCT02055625,Graft -Versus-host-disease,Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease,Mesenchymal stromal cells,Treatment of Oral Mucosa in Patients With Graft-versus-host Disease Following Injection of Mesenchymal Stem Cells - Human Pilot Study,Stockholm,Huddinge,Sweden,January 2014
79,80,NCT04525378,"Covid19|ARDS, Human",MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,Mesenchymal stromal cell-based therapy,Mesenchymal Stromal Cell-based Therapy for COVID-19-associated Acute Respiratory Distress Syndrome: a Pilot Clinical Study,Salvador,Bahia,Brazil,"July 1, 2020"
80,81,NCT03522545,Treatment-resistant Bipolar Depression,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)|Placebo,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,Houston,Texas,United States,"June 1, 2021"
81,82,NCT04400032,Acute Respiratory Distress Syndrome|Covid19,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,Mesenchymal Stromal Cells,Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19),Ottawa,Ontario,Canada,"May 15, 2020"
82,83,NCT03810521,"Osteoarthritis, Knee",Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis,umbilical cord derived-mesenchymal stromal cells,A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1),Santiago,Xiii,Chile,"March 1, 2019"
83,84,NCT04711200,Epidermal Necrolysis|Lyell Syndrome|Toxic Epidermal Necrolysis|Overlap Syndrome|Mesenchymal Stromal Cells|Adipose Derived Stromal Cells,LYell SYndrome MEsenchymal Stromal Cells Treatment,Adipose derived stromal cells intravenously injected,Mesenchymal Stromal Cells Treatment in Lyell Syndrome: A Pilot Phase 1-2 Open Trial,,,,September 2022
84,85,NCT05283317,Sepsis|Septic Shock,Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock,Mesenchymal stem cells,The Effect of Mesenchymal Stromal Cells on the Mortality of Patients With Sepsis and Septic Shock: A Promising Therapy,Kayseri,,Turkey,"March 11, 2018"
85,86,NCT05465096,Hip Osteoarthritis|Hip Disease,Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.,Micro-fragmented adipose tissue injection,Interventional Pilot Study on the Treatment of Osteoarthritis of the Hip Joint With Intra-articular Ultrasound-guided Infiltration of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells,Bologna,,Italy,September 2022
86,87,NCT03007576,"Osteoarthritis,Knee",Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem),RegStem,Phase I Clinical Trial - Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem),Taipei,,Taiwan,"August 1, 2017"
87,88,NCT04290182,Hoarseness|Dysphonia|Aphonia|Vocal Fold; Scar,A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring,MSC-KI-PL-204,"An Open Phase I/II Study in Patients With Dysphonia and Vocal Fold Scarring to Evaluate Safety, Tolerability and Vocal Function After Surgery With Local Administration of Autologous Mesenchymal Stromal Cells",Stockholm,,Sweden,March 2020
88,89,NCT04399889,COVID|Corona Virus Infection|COVID19,hCT-MSCs for COVID19 ARDS,Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.|Placebo,Pilot Study of Safety and Efficacy of Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC) in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS),Boca Raton|Miami|Miami|Valhalla|Durham,Florida|Florida|Florida|New York|North Carolina,United States|United States|United States|United States|United States,"June 18, 2020"
89,90,NCT03828123,"Motor Neuron Disease, Amyotrophic Lateral Sclerosis",Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis,Suspension of human autologous MSC 3P in 1.5 ml,"A Prospective, Non-randomized, Open Label Study to Assess the Safety and the Efficacy of Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis",,,,January 2012
90,91,NCT04744116,Hematopoietic and Lymphoid Cell Neoplasm|Steroid Refractory Graft Versus Host Disease,Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease,Cellular Therapy|Ruxolitinib,A Randomized Controlled Pilot Study of Two Doses of Cord Blood Tissue-Derived Mesenchymal Stromal Cells Combined With Ruxolitinib Versus Ruxolitinib Alone for Therapy of Steroid-Refractory Acute Graft Versus Host Disease,Houston,Texas,United States,"February 17, 2021"
91,92,NCT04489732,Xerostomia Following Radiotherapy,MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer,"Autologous bone-marrow derived, interferon gamma stimulated mesenchymal stromal cells",Pilot Study of Mesenchymal Stromal Cells in Patients With Xerostomia After Radiation Therapy for Head and Neck Cancer,Madison,Wisconsin,United States,"February 18, 2022"
92,93,NCT02709343,Chronic Lung Allograft Dysfunction (CLAD),Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction,Bone-marrow derived MSCs|Placebo,Phase 2 Randomised Controlled Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction (CLAD),Sydney|Brisbane|Adelaide|Melbourne|Murdoch,New South Wales|Queensland|South Australia|Victoria|Western Australia,Australia|Australia|Australia|Australia|Australia,"April 21, 2017"
93,94,NCT03504241,Kidney Transplantation|Renal Transplantation|Renal Transplant Recipient,Tolerance by Engaging Antigen During Cellular Homeostasis,Donor-derived Mesenchymal Stromal Cells|alemtuzumab|belatacept|sirolimus|mycophenolate mofetil|mycophenolate acid|prednisone,"Donor-derived Mesenchymal Stromal Cells, Alemtuzumab, Co-stimulation Blockade and Sirolimus for Tolerance Induction in Adult Kidney Allograft Recipients (ITN062ST)",Durham,North Carolina,United States,"July 30, 2018"
94,95,NCT05456243,Kidney Transplant,Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients,Low dose adipose tissue derived mesenchymal stromal cells (A-MSC)|High dose adipose tissue derived mesenchymal stromal cells (A-MSC),Safety of Intraarterial Infusion of Adipose Tissue-derived Mesenchymal Stromal Cells to Treat Antibody-mediated and Cellular Rejection in Adult Kidney Transplant Recipients (AMSCAR),Rochester,Minnesota,United States,October 2022
95,96,NCT04366830,Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",Remestemcel-L,"Intermediate-size Expanded Access of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells for Acute Respiratory Distress Syndrome Due to COVID-19 Infection",New York,New York,United States,
96,97,NCT04435249,Bronchopleural Fistula,ENgineered Tissue Repair of BronchopleUral fiSTula,BPF-001,"Phase I/II, Open Label Study to Assess the Safety and Efficacy Autologous Bone Marrow-derived Mesenchymal Stromal Cells Seeded on to Decellularised Airway Scaffold in Subjects With Clinically Significant Bronchopleural Fistula",,,,October 2022
97,98,NCT04325594,Chronic Heart Failure|Non-ischemic Cardiomyopathy|Non-ischemic Dilated Cardiomyopathy,The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Chronic Heart Failure of Non-ischemic Etiology,Cardiac catheterization|Intracoronary administration of the umbilical cord-derived mesenchymal stromal cells,Optimization of the Complex Treatment of Nonischemic Dilated Cardiomyopathy Due to the Addition to the Standard Drug Therapy of Intracoronary Administration of Umbilical Cord-derived Mesenchymal Stromal Cells,Taraz,Zhambyl,Kazakhstan,"March 1, 2020"
98,99,NCT04971161,Skin Ulcer Venous Stasis Chronic,Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb),allo-APZ2-CVU|Placebo,"A Randomized, Placebo-Controlled, Double-blind, Dose-Ranging, Multicenter, Phase IIb Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Therapy-Resistant Chronic Venous Ulcer (CVU)",Augsburg|Bad Bentheim|Berlin|Berlin|Berlin|Bochum|Bochum|Braunschweig|Bremerhaven|Dresden|Dresden|D√ºsseldorf|Erlangen|Essen|Freiburg|Gelsenkirchen|Gera|Halle|Hamburg|Hanau|Karlsbad|Kiel|Krefeld|Langenau|Leipzig|Leipzig|Ludwigshafen|Memmingen|M√ºnchen|M√ºnchen|M√ºnster|N√ºrnberg|Potsdam|Regensburg|Rostock|Schwerin|Stuttgart|T√ºbingen|Wuppertal|W√ºrzburg,,Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany,"August 18, 2021"
99,100,NCT04896853,COVID-19 Acute Respiratory Distress Syndrome,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans¬Æ,ProTrans¬Æ,Treatment of Respiratory Complications Associated With COVID-19 Infection Using Wharton's Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans¬Æ): Open Phase IB Clinical Trial,√ñrebro,,Sweden,"May 18, 2021"
100,101,NCT03209700,Perianal Fistula|Cryptoglandular Perianal Fistula|Crohn's Perianal Fistula,Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas,MSC-AFP,Re-treatment for Partial or Non-responders for a Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Perianal Fistulas,Rochester,Minnesota,United States,"July 20, 2017"
101,102,NCT03406585,Type1 Diabetes Mellitus,Wharton¬¥s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes,ProTrans: Allogeneic transplantation with WJMSCs|Placebos,"A Double-blinded, Randomized, Placebo-controlled Trial With Wharton's Jelly Derived Allogeneic Mesenchymal Stromal Cells (WJMSCs) for Preserving Endogenous Insulin Production in Adult Patients Diagnosed for Type 1 Diabetes",Stockholm,,Sweden,"November 28, 2017"
102,103,NCT05464381,Epidermolysis Bullosa,"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)",allo-APZ2-OTS|Placebo,"A Double-blind, Randomized, Placebo-controlled, Interventional, Multicenter, Phase III Clinical Trial to Investigate the Safety and Efficacy of ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs) on Epidermolysis Bullosa (EB)",,,,December 2022
103,104,NCT01860417,Degenerative Disc Disease|Intervertebral Disc Disease|Low Back Pain,Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV),Allogenic Mesenchymal Stromal Cells|Mepivacaine,Treatment of Lumbar Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Bone Marrow Mesenchymal Stromal Cells Expanded Using the Valladolid IBGM Procedure,Valladolid|Valladolid,,Spain|Spain,April 2013
104,105,NCT02336230,Grade B aGVHD|Grade C aGVHD|Grade D aGVHD,"A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",remestemcel-L,"A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD",Los Angeles|Orange|San Francisco|Aurora|Wilmington|Miami|Chicago|Detroit|Jackson|Saint Louis|New York|New York|New York|Durham|Portland|Charleston|San Antonio|Richmond|Seattle|Milwaukee,California|California|California|Colorado|Delaware|Florida|Illinois|Michigan|Mississippi|Missouri|New York|New York|New York|North Carolina|Oregon|South Carolina|Texas|Virginia|Washington|Wisconsin,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States,"June 4, 2015"
105,106,NCT02997878,"Cholangitis, Sclerosing|Hepatitis, Autoimmune","A Single-arm,Phase IIa,Safety and Efficacy Trial of Selected MSCs in the Treatment of Patients With PSC & AiH",Orbcel-C,"An Adaptive,Multicentre, Phase IIa, Multi-disease Trial Investigating the Safety & Activity of a Single Infusion of Selected Mesenchymal Stromal Cells in the Treatment of Patients With Primary Sclerosing Cholangitis & Autoimmune Hepatitis",Birmingham,West Midlands,United Kingdom,"December 7, 2018"
106,107,NCT01586312,"Osteoarthritis, Knee|Arthritis of Knee|Knee Osteoarthritis",Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells,Allogenic mesenchymal stromal cells injection|Hyaluronic Acid,Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Mesenchymal Stromal Cells From Valladolid,Barcelona|Valladolid,,Spain|Spain,April 2012
107,108,NCT04869397,Covid19,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,Allogeneic Wharton's jelly-MSCs (WJ-MSC)|Placebo,Treatment of Respiratory Complications Associated With COVID-19 Infection Using Wharton's Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans¬Æ): a Randomized Phase II Controlled Clinical Trial,Montreal,Quebec,Canada,"June 14, 2021"
108,109,NCT03901235,Efficacy and Safety,MSC Intratissular Injection in Crohn Disease Patients,Mesenchymal Stromal Cells,Treatment of Refractory Crohn's Disease Lesions by Local Injection of Mesenchymal Stem Cells,Li√®ge,,Belgium,"January 15, 2018"
109,110,NCT01922908,Ischemic Stroke,Mesenchymal Stromal Cells for Ischemic Stroke,MSC Infusion|Placebo Comparator,SAfety of Mesenchymal Stromal Cells for Ischemic Stroke,,,,December 2016
110,111,NCT04341610,Respiratory Tract Diseases,ASC Therapy for Patients With Severe Respiratory COVID-19,Stem Cell Product,"Allogeneic Adipose Tissue Derived Mesenchymal Stromal Cell Therapy for Treating Patients With Severe Respiratory COVID-19. A Danish, Double-blind, Randomized Placebo-controlled Study",Copenhagen,,Denmark,"April 20, 2020"
111,112,NCT02270307,Leukemia|Multiple Myeloma,MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis,Cyclophosphamide|Mesenchymal stromal cells,Allogeneic Bone Marrow Transplantation (Allo-BMT) From Human Leukocyte Antigen (HLA) - Identical Related and Unrelated Donors in Patients With Hematological Malignancies With High Risk of Relapse Using Cyclophosphamide (CY) and Mesenchymal Stromal Cells (MSC) as aGVHD Prophylaxis,Moscow,,Russian Federation,January 2014
112,113,NCT02033525,Chronic Meniscal Injury,Mesenchymal Stromal Cells for Degenerative Meniscus Injury,XCEL-M-ALPHA and standard rehabilitation|Rehabilitation,A Phase I-IIa Safety and Efficacy Pilot Clinical Trial of Intraarticular Administration of Autologous Mesenchymal Cells for Meniscus Injury,Barcelona,,Spain,"January 31, 2014"
113,114,NCT04018729,Chronic Obstructive Pulmonary Disease Severe,Cell Therapy Associated With Endobronchial Valve,Zephyr Endobronchial Valve|Marrow-derived mesenchymal stromal cell,Bone Marrow-Derived Mesenchymal Stromal Cell Therapy Associated With Unidirectional Endobronchial Valve in Patients With Severe Pulmonary Emphysema: A Randomized Clinical Trial,,,,"November 4, 2019"
114,115,NCT05433298,COVID-19 Pneumonia|COVID-19,Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.,Mesenchymal stem cell|Placebo,Multicenter Phase I/IIa Study of Mesenchymal Stromal Cells for the Treatment of Patients With SARS-CoV-2 Pneumonia.,Curitiba,Paran√°,Brazil,"May 1, 2022"
115,116,NCT05095532,Chronic Pancreatitis|Mesenchymal Stem Cells,Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT,Bone marrow-derived mesenchymal stem cells|Placebo,Autologous Mesenchymal Stromal Cells and Islet Co-transplantation to Enhance Islet Survival and Function in Chronic Pancreatitis Patients Undergo Total Pancreatectomy and Islet Autotransplantation,Charleston,South Carolina,United States,"December 1, 2021"
116,117,NCT02585622,Diabetic Kidney Disease,NEPHSTROM for Diabetic Kidney Disease,Mesenchymal Stromal Cells|Placebo,Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM Study),Galway|Bergamo|Belfast|Birmingham,BG,Ireland|Italy|United Kingdom|United Kingdom,"December 11, 2017"
117,118,NCT02165904,Spinal Cord Injury,Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in SCI,Adult Autologous Mesenchymal Bone Marrow Cell,Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in Patients Suffering Incomplete Spinal Cord Injury (SCI),Majadahonda,Madrid,Spain,May 2014
118,119,NCT02603744,Premature Ovarian Failure,Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF),Intraovarian injection of Adipose derived Stromal cells (ADSCs),Evaluate the Safety and Feasibility of Intra-ovarian Injection of Autologous Adipose Derived Mesenchymal Stromal Cells (ADMSC) in Women With Premature Ovarian Failure(POF),Tehran,,"Iran, Islamic Republic of",June 2015
119,120,NCT04815213,Premature Ovarian Failure,The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans,expanded autologous bone marrow derived MSC,The Use of Expanded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans: Phase I Clinical Trial,Amman,,Jordan,"January 1, 2020"
120,121,NCT03015623,Acute Kidney Injury,A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy,SBI-101|Sham,"A Multi-center, Randomized, Sham-controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 Therapy) in Subjects With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy",Allentown,Pennsylvania,United States,"June 20, 2017"
121,122,NCT03651791,Ischemic Heart Disease,In Vivo Tracking of USPIO Labeled MSC in the Heart,USPIO labeled MSC injection,In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled With Ultra-Small Paramagnetic Iron Oxide Particles After Intramyocardial Transplantation in Patients With Chronic Ischemic Heart Disease,,,,May 2013
122,123,NCT05490173,"Premature Birth|Extreme Prematurity|Preterm Intraventricular Hemorrhage|Hypoxia-Ischemia, Cerebral|Neurodevelopmental Disorders",The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants,Exosomes derived from mesenchymal stromal cells (MSCs),The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants,Moscow,,Russian Federation,"October 5, 2022"
123,124,NCT05131412,Pneumonia|Hematopoietic Stem Cell Transplantation,Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation,,Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation: a a Retrospective Cohort Study,Guangzhou,Guangdong,China,"August 8, 2018"
124,125,NCT04445220,COVID-19|Acute Kidney Injury|Sepsis,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,SBI-101,"A Multi-center, Randomized, Case Controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 Therapy) in COVID-19 Subjects With Acute Kidney Injury Receiving Renal Replacement Therapy",Albuquerque|Charleston,New Mexico|South Carolina,United States|United States,"November 19, 2020"
125,126,NCT04210440,Hip Necrosis|Hip Injuries,The Treatment of Initial Stage of Hip Osteonecrosis: the Core Decompression,Core decompression procedure,Core Decompression With Bone Chips Allograft Adjuvanted by Fibrin Platelet Rich-plasma (PRP) and Concentrated Autologous Mesenchymal Stromal Cells (MSCS): Results in Avascular Necrosis of Femoral Head (AVN) After 2 Years Minimum Follow-up,Bologna,,Italy,"March 1, 2003"
126,127,NCT04456439,Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19),"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",Remestemcel-L|Hydrocortisone|Diphenhydramine,"Intermediate-size Expanded Access of Remestemcel-L, Human Mesenchymal Stromal Cells, for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",,,,
127,128,NCT04629833,Steroid-refractory Acute Graft-versus-host Disease,Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy,MC0518|BAT,"A Randomised, Open-label, Multicentre, Phase 3 Trial of First-line Treatment With Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects With Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)",Grenoble|Lille|Nice|Pierre Benite Cedex|Rennes|Toulouse|Vandoeuvre les Nancy|Munich|W√ºrzburg|Frankfurt am Main|Hannover|M√ºnster|Essen|Koeln|Dresden|Leipzig|Jena|Jena|Berlin|Bonn|Essen|Frankfurt|Freiburg|Mainz|Mannheim|Tuebingen|Wroc≈Çaw|Barcelona|Barcelona|Barcelona|Barcelona|Barcelona|Madrid|Madrid|Valencia|Huddinge,Bavaria|Bavaria|Hessen|Niedersachsen|Nordrhein-Westfalen|North Rhine-Westphalia|North Rhine-Westphalia|Sachsen|Saxony|Th√ºringen|Th√ºringen|Dolnoslaskie,France|France|France|France|France|France|France|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Germany|Poland|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Sweden,"August 16, 2021"
128,129,NCT02838069,Osteoarthritis,A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis,Injection (2x106 ASC/5ml).|Injection (10x106 ASC/5ml).|Placebo,"A Phase IIb, Prospective, Multicentre, Double-blind, Triple-arm, Randomized Versus Placebo Trial, to Assess the Efficacy of a Single Injection of Either 2 or 10 x 106 Autologous Adipose Derived Mesenchymal Stromal Cells (ASC) in the Treatment of Mild to Moderate Osteoarthritis (OA) of the Knee, Active and Unresponsive to Conservative Therapy for at Least 12 Months",Montpellier,,France,"September 20, 2016"
129,130,NCT04371393,Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID,MSCs in COVID-19 ARDS,Remestemcel-L|Placebo,Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome,Gilbert|Los Angeles|Stanford|Atlanta|Fort Wayne|New Orleans|Portland|Baltimore|Boston|Ann Arbor|Lebanon|New York|New York|New York|Durham|Raleigh|Cleveland|Philadelphia|Houston|Plano|Charlottesville,Arizona|California|California|Georgia|Indiana|Louisiana|Maine|Maryland|Massachusetts|Michigan|New Hampshire|New York|New York|New York|North Carolina|North Carolina|Ohio|Pennsylvania|Texas|Texas|Virginia,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States,"April 30, 2020"
130,131,NCT02382874,Focal Segmental Glomerulosclerosis,Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis),Intravenous injection,"Allogenic Adipose Derived Mesenchymal Stromal Cells Transplantation to Improve Kidney Function in Refractory Primary Nephrotic Syndrome (Focal Segmental Glomerulosclerosis,FSGS) ,a Phase I Clinical Trial",Tehran,,"Iran, Islamic Republic of",May 2015
131,132,NCT02448849,Bone Fracture,Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment,Percutaneous injection|Percutaneous injection,"Use of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Combination With Platelet Lysate Product for Human Long Bone Nonunion Treatment, A Phase 2-3 Clinical Trial",Tehran,,"Iran, Islamic Republic of",June 2015
132,133,NCT04397471,Healthy Volunteers for Bone Marrow Donation,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,Bone Marrow Harvest,A Study to Collect Bone Marrow for Process Development and Production of Bone Marrow Mesenchymal Stromal Cells to Treat Severe COVID19 Pneumonitis,Cambridge,Cambridgeshire,United Kingdom,May 2020
133,134,NCT04294290,Autism Spectrum Disorder,Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder,hCT-MSC infusion,"AN OPEN LABEL PHASE I STUDY OF hCT-MSC, AN UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELL PRODUCT IN YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDER",Durham,North Carolina,United States,"February 24, 2021"
134,135,NCT03608579,"Osteoarthritis, Hip",Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA,Autologous Adipose Derived Mesenchymal Stromal Cells,ASCLEPIOS Autologous Stem CelL Expansion and Prospective Injection for Osteoarthritic Hip Symptoms,Rochester,Minnesota,United States,"November 5, 2018"
135,136,NCT01915927,Perianal Crohn's Disease,Stem Cell Fistula Plug in Perianal Crohn's Disease,MSC-AFP,A Phase 1 Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease.,Rochester,Minnesota,United States,July 2013
136,137,NCT02145923,Neutropenic Enterocolitis|Myeloablative Chemotherapy Induced Bone Marrow Aplasia,Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis,Peripheral blood stem cell mobilisation and collection|High-dose chemotherapy|Bone marrow derived allogeneic MMSCs infusion|Autologous peripheral blood stem cells infusion,Effectiveness and Safety of Intravenous Infusion of Bone Marrow Derived Allogeneic Multipotent Mesenchymal Stromal Cells for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis in Hematological Patients With Aplasia After High-dose Chemotherapy.,Moscow,,Russian Federation,May 2014
137,138,NCT03473301,Cerebral Palsy,A Study of UCB and MSCs in Children With CP: ACCeNT-CP,Infusion of allogeneic umbilical cord blood|Infusion of MSCs,A Phase I/II Study of Allogeneic Umbilical Cord Blood and Umbilical Cord Tissue-Derived Mesenchymal Stromal Cell Infusions in Children With Cerebral Palsy,Durham,North Carolina,United States,"April 10, 2018"
138,139,NCT01909154,Spinal Cord Injury,Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia,Mesenchymal stromal cell therapy,"Phase I Pilot Study to Evaluate the Security of Local Administration of Autologous Stem Cells Obtained From the Bone Marrow Stroma, in Traumatic Injuries of the Spinal Cord",Majadahonda,Madrid,Spain,March 2013
139,140,NCT04484077,Autism Spectrum Disorder|Autism,hCT-MSC Infusion in Adults With Autism Spectrum Disorder,hCT-MSC,"A PHASE I STUDY OF hCT-MSC, AN UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELL PRODUCT, IN ADULTS WITH AUTISM SPECTRUM DISORDER",Durham,North Carolina,United States,"January 24, 2022"
140,141,NCT02829216,Abnormal Hematopoiesis|Allogenic Disease|Graft vs Host Disease,Graft-versus-host Disease Associated Myelosuppression,,Functional Profiling of the Hematopoietic Stem Cell Niche in Graft Versus Host Disease Mediated Bone Marrow Insufficiency,Dresden,,Germany,April 2016
141,142,NCT02351011,Osteoarthritis of Knee,Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA,1 x 10^6 MSCs|10 x 10^6 MSCs|50 x 10^6 MSCs,Human Autologous Mesenchymal Stromal Cells for the Treatment of Mid to Late Stage Knee Osteoarthritis,Toronto,Ontario,Canada,February 2015
142,143,NCT00260338,Myocardial Ischemia|Coronary Heart Disease,Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia,stem cell,Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia,Copenhagen,,Denmark,December 2005
143,144,NCT02181478,Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Myelodysplastic Syndromes|Myelofibrosis|Relapsed Non-Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Hodgkin Lymphoma|Refractory Hodgkin Lymphoma|Relapsed Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia|Lymphoid Malignancies|Chronic Myelogenous Leukemia,Intra-Osseous Co-Transplant of UCB and hMSC,cyclophosphamide|fludarabine phosphate|total-body irradiation|cyclosporine|mycophenolate mofetil|umbilical cord blood transplantation|mesenchymal stem cell transplantation,Intra-osseous Co-transplant of Cord Blood and Mesenchymal Stromal Cells: A Feasibility Study,Cleveland,Ohio,United States,"July 22, 2015"
144,145,NCT03389919,Mesenchymal Stem Cell Transplantation,Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT,MSC administration (intraosseal),EFFECTIVENESS AND SAFETY OF INTRAOSSEOUS ADMINISTRATION OF MESENCHYMAL STORMAL CELLS FOR PRIMARY GRAFT FAILURE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION,Moscow,,Russian Federation,"January 1, 2017"
145,146,NCT02630836,Femoral Neck Fracture,Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture,XCEL-MT-OSTEO-BETA|Surgical treatment,A Pilot Clinical Trial of ex Vivo Expanded Allogenic Adult Stem Cells Combined With Allogenic Human Bone Tissue (XCEL-MT-OSTEO-BETA) in Proximal Femur Fractures in Elderly Patients,,,,December 2015
146,147,NCT03099239,Autism|Autism Spectrum Disorder|ASD,hCT-MSCs for Children With Autism Spectrum Disorder (ASD),hCT-MSC infusion,"A Phase I Study of hCT-MSC, An Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder",Durham,North Carolina,United States,"June 6, 2017"
147,148,NCT01585857,Osteoarthritis,ADIPOA - Clinical Study,Autologous adipose derived stem cells administrated for intra-articular use|Autologous adipose derived stem cells administrated for intra-articular use,"A Phase I, Prospective, Bi-centric,Single -Arm, Open-label, Dose-escalating Clinical Trial to Evaluate the Safety of a Single Injection of Autologous Adipose Derived Mesenchymal Stromal Cells in the Treatment of Severe Osteoarthritis of the Knee Joint",Montpellier|W√ºrzburg,,France|Germany,April 2012
148,149,NCT03113747,Second- or Third-degree Burns,Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs),ALLO-ASCs,Safety and Efficacy Evaluation of Tissue Engineered Construct Based on Allogeneic Adipose-derived Multipotent Mesenchymal Stromal Cells and Platelet-poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds,Kyiv,,Ukraine,"March 25, 2015"
149,150,NCT05491135,Acute Liver Failure,Hepatocyte Microbeads for Acute Liver Failure,HMB002,Hepatocytes Co-Encapsulated With Mesenchymal Stromal Cells in Alginate Microbeads for the Treatment of Acute Liver Failure in Paediatric Patients (HELP),,,,September 2022
150,151,NCT02706132,Liver Transplantation,Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation,Mesenchymal Stem Cells(MSCs),MSC for ABO Incompatible Liver Transplantation,Guangzhou,Guangdong,China,February 2014
151,152,NCT04545307,Pulp Necroses|Apical Periodontitis,Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis,Allogenic transplant of BM-MSC in a root canal from patients with immature apexes and pulpar necrosis and apical periodontitis,Transplantation of Allogeneic Mesenchymal Stromal Cells in Patients With Immature Apex Teeth With Pulp Necrosis and Chronic Apical Periodontitis,San Antonio de los Altos,Miranda,Venezuela,"November 27, 2019"
152,153,NCT04007081,Xerostomia|Head and Neck Cancer,Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia,Bone Marrow Aspiration|Ultrasound Imaging of Salivary Glands|Salivary Assay|Quality of Life Instruments,Salivary Gland Autotransplantation of Marrow Mesenchymal Stromal Cells for Treatment of Radiation-induced Xerostomia - FDA IND (Investigational New Drug) Enabling Studies,Madison,Wisconsin,United States,"October 18, 2019"
153,154,NCT01686139,Type I Diabetes Mellitus With Ulcer|Type II Diabetes Mellitus With Ulcer,Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers,ABMD-MSC,Phase 1 Study: Treatment of Patients With Diabetic Foot Complications With Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells (ABMD-MSC),Ramat Gan,,Israel,March 2016
154,155,NCT01275612,Solid Tumors|Acute Kidney Injury,Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers,Mesenchymal stromal cell infusion,Ex-Vivo Expanded Mesenchymal Stem Cells To Repair The Kidney And Improve Function In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers,Bergamo,BG,Italy,November 2010
155,156,NCT05333029,Graft Versus Host Disease,Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD,Allogeneic mesenchymal stromal cells (MSCs)|Extracorporeal photopheresis (ECP),A Phase II Study of Combination Treatment With Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for High-Risk and Steroid-Refractory Acute GVHD,Cleveland,Ohio,United States,October 2022
156,157,NCT03673748,Lupus Nephritis|Lupus Erythematosus,Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells,Mesenchymal stromal cells (MSC)|Placebo,A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Lupus Nephritis,Valladolid,,Spain,December 2022
157,158,NCT02274428,Mesenchymal Stromal Cells,Phase 1 Clinical Trial of PNEUMOSTEM¬Æ Treatment in Premature Infants With Intraventricular Hemorrhage,pneumostem,Phase 1 Clinical Trial of PNEUMOSTEM¬Æ Treatment in Premature Infants With Intraventricular Hemorrhage,Seoul,,"Korea, Republic of",October 2014
158,159,NCT03635450,Moderate to Severe Hypoxic-ischemic Encephalopathy,Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE,Infusion of hCT-MSC,"A Phase I Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Newborn Infants With Moderate or Severe Hypoxic- Ischemic Neonatal Encephalopathy.",Durham,North Carolina,United States,"December 27, 2018"
159,160,NCT01463475,Graft Versus Host Disease (GVHD)|Acute Myocardial Infarction (AMI),University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol,Bone marrow aspirate,University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol,Madison,Wisconsin,United States,September 2011
160,161,NCT02409940,Renal Transplant Rejection,To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients,Mesenchymal Stem Cells,A Randomized Trial to Elucidate Effect of Mesenchymal Stem Cells on Immune Modulation in Living Related Kidney Transplant Patients,Chandigarh,,India,September 2013
161,162,NCT02195323,Chronic Kidney Disease,Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD),Intravenous injection,Administration of Autologous Bone Marrow Mesenchymal Stem Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD),Tehran,,"Iran, Islamic Republic of",April 2014
162,163,NCT03171194,System; Lupus Erythematosus,Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus,Low Dose Mesenchymal Stem Cells (MSCs),A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus,Atlanta|Charleston,Georgia|South Carolina,United States|United States,"April 27, 2017"
163,164,NCT02801890,Ultra Filtration Failure,Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF),Intravenous injection,Autologous AD-MSC Transplantation in Peritoneal Dialysis Patients With Ultra Filtration Failure and Evaluation of Cellular and Molecular Effects of Mesenchymal Stem Cell Infusion on Peritoneal Fibrosis,Tehran,,"Iran, Islamic Republic of",August 2015
164,165,NCT04466007,Limb Ischemia|Diabetic Foot,Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia,High dose allogeneic mesenchymal stromal cells|Low dose allogeneic mesenchymal stromal cells|Placebos,"Multicenter, Randomized, Dose-search, Parallel, Double-blind, and Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Intramuscular Administration of Allogeneic Adipose Tissue Adult Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia Without Possibility of Revascularization",Alicante|Madrid|Madrid|Madrid|Murcia|Pamplona|Salamanca|Sevilla|Valencia|Valladolid,,Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain,"January 11, 2021"
165,166,NCT03356821,Perinatal Arterial Ischemic Stroke|Neonatal Stroke,Perinatal Arterial Stroke Treated With Stromal Cells Intranasally,Mesenchymal Stem Cells,Adult Mesenchymal Stromal Cells to Regenerate the Neonatal Brain: the PASSIoN Trial (Perinatal Arterial Stroke Treated With Stromal Cells IntraNasally),Utrecht,,Netherlands,"February 11, 2020"
166,167,NCT03909139,Acetabular Labrum Tear|Femoro Acetabular Impingement|Chondral Defect|Bone Marrow Aspirate Concentrate|Mesenchymal Stromal Cell,Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear,BMAC,Prospective PROMs Outcomes in Arthroscopic Acetabular Labral Repair With and Without Application of Platelet-Rich Plasma (PRP) Harvested From the Body of the Ilium,Boston,Massachusetts,United States,"September 6, 2019"
167,168,NCT02247973,Severe Aplastic Anemia,Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.,mesenchymal stem cells|mesenchymal stem cells,Phase‚Ö°Trial of Co-transplantation With Bone Marrow Derived Mesenchymal Stem Cells From Related Donors in Alternative Donor Transplantation of Severe Aplastic Anemia.,Guangzhou,Guangdong,China,February 2013
168,169,NCT02940418,Diabetes Mellitus Type 1,Use of Stem Cells in Diabetes Mellitus Type 1,Adipose mesenchymal cells with bone marrow mononuclear cells,The Use of Mesenchymal Stromal Cells (MSC) in Type 1 Diabetes Mellitus in Adult Humans: Phase I Clinical Trial,Amman,,Jordan,"February 19, 2017"
169,170,NCT01840540,Atherosclerotic Renal Artery Stenosis|Ischemic Nephropathy|Renovascular Hypertension,MSC for Occlusive Disease of the Kidney,Arterial infusion of autologous mesenchymal stem cells,Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis,Rochester,Minnesota,United States,April 2013
170,171,NCT04247945,Allogeneic Hematopoietic Stem Cell Transplantation,Co-transplantation of MSC in the Setting of Allo-HSCT,Cotransplant with MSCs,Co-transplantation of Mesenchymal Stromal Cells in Allogeneic Hematopoietic Stem Cell Transplantation,Fuzhou,Fujian,China,"February 1, 2020"
171,172,NCT03369275,Septic Shock|Sepsis|Pathologic Processes|Shock|Infection|Systemic Inflammatory Response Syndrome|Inflammation,Cellular Immunotherapy for Septic Shock,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|Placebo,Cellular Immunotherapy for Septic Shock (CISS2) A Phase II Randomized Controlled Trial,,,,March 2018
172,173,NCT02408432,Cardiomyopathy|Heart Failure,Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines,Laboratory Biomarker Analysis|Standard of Care|Mesenchymal Stem Cell Transplantation,Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy,Houston,Texas,United States,"January 11, 2016"
173,174,NCT05060107,"Osteoarthritis, Knee",Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1),Exosomes (sEVs),A Phase I Study Aiming to Assess Safety and Efficacy of a Single Intra-articular Injection of MSC-derived Exosomes (CelliStem¬ÆOA-sEV) in Patients With Moderate Knee Osteoarthritis (ExoOA-1),,,,"October 5, 2021"
174,175,NCT03795974,"Cerebral Palsy, Spastic",Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy,MNC|MSC|Control,"Evaluation of the Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Patients With Spastic Cerebral Palsy on Developmental Function , A Clinical Trial phase2",Tehran|Tehran|Tehran|Tehran,,"Iran, Islamic Republic of|Iran, Islamic Republic of|Iran, Islamic Republic of|Iran, Islamic Republic of","July 23, 2017"
175,176,NCT04723303,Polymyositis|Dermatomyositis,Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM),Umbilical Cord Lining Stem Cells,"Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)",Gainesville,Florida,United States,"October 6, 2021"
176,177,NCT03258164,Breast Hypoplasia and Facial Ageing,Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts,ASC enriched lipofilling|Standard Lipofilling,Fat Transplantation Enriched With Expanded Adipose-derived Autologous Mesenchymal Stromal Cells in Cosmetic Breast Augmentation and Cosmetic Facial Filling,Copenhagen,S√∏borg,Denmark,"March 22, 2017"
177,178,NCT02962661,Cardiomyopathy|Heart Failure|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines,Best Practice|Laboratory Biomarker Analysis|Mesenchymal Stem Cell Transplantation|Mesenchymal Stem Cell Transplantation,Randomized 3-Arm Trial With Standard of Care Alone vs Either Intravenous Infusion or Transendocardial Injection of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) Plus Standard of Care in Patients With Anthracycline-Associated Cardiomyopathy,Houston,Texas,United States,"July 18, 2020"
178,179,NCT04126603,"Diabetes Mellitus, Type 2",Impact of Semaglutide on CD34+ EPC and Fat Derived MSC,Semaglutide|Placebos,Impact of Semaglutide (Long Acting GLP1 Agonist) on Peripheral Blood Derived CD34+ Endothelial Cells (EPCs) and Subcutaneous Fat Derived Mesenchymal Stromal Cells ( MSCs) in Type 2 Diabetes Subjects,Washington,District of Columbia,United States,"August 1, 2019"
179,180,NCT01624701,Acute Leukemia|Chronic Leukemia|Myelodysplastic Syndrome|Lymphoma|Myeloma,Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells,Ex vivo expanded cord blood cells,Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells: A Pilot Trial in Collaboration With the Massachusetts Institute of Technology,Singapore,,Singapore,March 2012
180,181,NCT03298763,Adenocarcinoma of Lung,Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer,MSCTRAIL|Placebo,Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer,London,,United Kingdom,"March 5, 2019"
181,182,NCT02209311,Partially Edentulous Maxilla|Alveolar Bone Atrophy|Alveolar Bone Loss,Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs,Oral mucosa biopsy|Sinus lift with implantation of tissue engineered construction|Dental implant,Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Tissue Engineered Construction Based on a Synthetic Tricalcium Phosphate and Autologous Multipotent Mesenchymal Stromal Cells Obtained From Oral Mucosa,Moscow|Moscow,,Russian Federation|Russian Federation,September 2014
182,183,NCT04390139,COVID-19|SARS-CoV 2|Adult Respiratory Distress Syndrome,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,XCEL-UMC-BETA|Placebo,"A Prospective, Double-blind, Randomized, Parallel, Placebo-controlled Pilot Clinical Trial for the Evaluation of the Efficacy and Safety of Two Doses of WJ-MSC in Patients With Acute Respiratory Distress Syndrome Secondary to Infection by COVID-19",Hospitalet de Llobregat|Terrassa|Barcelona|Barcelona|Barcelona,Barcelona|Barcelona,Spain|Spain|Spain|Spain|Spain,"May 13, 2020"
183,184,NCT05553132,Cartilage Defect,A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects,Autologous Chondrocytes in their Pericellular Matrix (Chondrons) Coimplanted with Allogeneic Adipose-Derived Mesenchymal Stromal Cells (AMSCs) in a Fibrin Glue Carrier,Hip RECLAIM: A Phase I Safety and Feasibility Trial of REcycled CartiLage Auto/Allo IMplantation for the Treatment and Repair of Focal Hip Cartilage Defects,Rochester,Minnesota,United States,October 2022
184,185,NCT02017912,Amyotrophic Lateral Sclerosis (ALS),"Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS",Autologous MSC-NTF cells|Placebo,"A Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study to Evaluate Safety and Efficacy of Transplantation of Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors (MSC-NTF) in Patients With ALS",Boston|Worcester|Rochester,Massachusetts|Massachusetts|Minnesota,United States|United States|United States,May 2014
185,186,NCT01606215,Multiple Sclerosis,Stem Cells in Rapidly Evolving Active Multiple Sclerosis,Mesenchymal stem cells|Placebo,Stem Cells in Rapidly Evolving Active Multiple Sclerosis,London,,United Kingdom,January 2013
186,187,NCT05008588,Ischemic Stroke,Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct,Conditioned Medium|Umbilical Cord Mesenchymal Stem Cells|Neurologic and Neutrophic Drugs,Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct,Jakarta Pusat|Jakarta,DKI Jakarta,Indonesia|Indonesia,"May 30, 2022"
187,188,NCT00908856,Stroke,Autologous Cell Therapy After Stroke,autologous bone marrow mononuclear cell transfusion|marrow stromal cells|placebo,Safety of IV Autologous Mononuclear Cells and Marrow Stromal Cells After Stroke,Orange,California,United States,January 2016
188,189,NCT03609905,Ulcerative Colitis (UC),Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis,Adipose-cord mesenchymal stromal cells (A-MSCs)|Conventional drugs,"A Phase I/II Randomized, Controlled, Clinical Trial for Assessment of the Safety and Efficacy of Allogeneic Adipose Mesenchymal Stem Cells in Moderate to Severe Ulcerative Colitis Patients",Liaocheng,Shandong,China,"July 1, 2018"
189,190,NCT03166865,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis,Umbilical-cord mesenchymal stromal cells (UC-MSCs)|Hyaluronic acid,Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis,Liaocheng,Shandong,China,"October 1, 2018"
190,191,NCT03028428,Osteoarthritis|Stem Cells|MSC,Intra-articular Injection of MSCs in Treatment of Knee OA,Placenta Derived Mesenchymal Stem Cell|Sodium Hyaluronate,Clinical Research on Intra-articular Injection of Human Autologous MSCs in Treatment of Knee OA,,,,December 2016
191,192,NCT00395200,Multiple Sclerosis,Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS),MSC Treatment,Autologous Adult Human Mesenchymal Stem Cells: a Neuroprotective Therapy for Multiple Sclerosis,Cambridge|London,Cambridgeshire,United Kingdom|United Kingdom,July 2008
192,193,NCT01730547,Multiple Sclerosis,Mesenchymal Stem Cells for Multiple Sclerosis,Autologous mesenchymal stem cells,Phase 1/2 Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis,Stockholm,,Sweden,February 2013
193,194,NCT04961658,Septic Shock,Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients,GEM00220,Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients,Oshawa|Toronto,Ontario|Ontario,Canada|Canada,"August 11, 2021"
194,195,NCT03799718,"Multiple Sclerosis, Chronic Progressive",Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS,NurOwn (MSC-NTF cells),"A Phase 2 Open-label Multicenter Study to Evaluate the Safety and Efficacy of Repeated Administration of NurOwn¬Æ [Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors (NTF), MSC-NTF] Cells in Participants With Progressive MS",Los Angeles|Redwood City|New York|Cleveland,California|California|New York|Ohio,United States|United States|United States|United States,"March 13, 2019"
195,196,NCT02685098,Ischemia|Peripheral Arterial Disease|Peripheral Vascular Disease|Vascular Disease|Arterial Occlusive Disease|Arteriosclerosis|Atherosclerosis|Cardiovascular Disease|Pathologic Processes|Orthopedic Procedures|Amputation,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,Allogeneic bone marrow derived mesenchymal stem cells,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,Indianapolis,Indiana,United States,January 2017
196,197,NCT03847844,Acute-graft-versus-host Disease,UCMSCs as Front-line Approach of Treatment for Patients With aGVHD,Umbilical cord derived mesenchymal stem cell|Placebo,Cytopeutics¬Æ Umbilical Cord Mesenchymal Stem Cells (Cyto-MSC) for Patients With Grade II -IV Acute Graft-Versus-Host Disease: A Phase I/II Clinical Study,Ampang,Selangor,Malaysia,"February 1, 2019"
197,198,NCT04061746,"Diabetes Mellitus, Type 1",Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,Mesenchymal Stem Cells (MSCs)|Placebo Infusion (Plasmalyte A with 0.5% human serum albumin),Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,Charleston,South Carolina,United States,"February 13, 2020"
198,199,NCT03280056,Amyotrophic Lateral Sclerosis (ALS),Safety and Efficacy of Repeated Administrations of NurOwn¬Æ in ALS Patients,NurOwn¬Æ (MSC-NTF cells)|Placebo|Bone Marrow aspiration,"A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn¬Æ (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS",Irvine|Los Angeles|San Francisco|Boston|Worcester|Rochester,California|California|California|Massachusetts|Massachusetts|Minnesota,United States|United States|United States|United States|United States|United States,"August 28, 2017"
199,200,NCT02812121,Liver Failure,UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure,umbilical cord blood mesenchymal stem cells,Umbilical Cord Blood Derived Mesenchymal Stem Cells Infusion for HBV-Related Acute-on-Chronic Liver Failure: A Randomized Controlled Trial,,,,June 2016
200,201,NCT01446614,Parkinson's Disease,Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease,bone marrow derived mesenchymal stem cells,Phase‚Ö†/‚Ö°Trial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Parkinson's Disease.,Guangzhou,Guangdong,China,October 2011
201,202,NCT01446640,Spinal Cord Injury,Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury,bone marrow derived mesenchymal stem cells,Phase‚Ö†/‚Ö°Trial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Spinal Cord Injury.,Guangzhou,Guangdong,China,October 2011
202,203,NCT01305694,Aplastic Anemia,Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.,bone marrow derived mesenchymal stem cells,Phase‚Ö†/‚Ö°Trial of Bone Marrow Derived Mesenchymal Stem Cell Transplantation From Related Donor to Patients With Relapsed/Refractory Aplastic Anemia.,Guangzhou,Guangdong,China,February 2011
203,204,NCT04432545,Systemic Sclerosis Pulmonary|Pulmonary Hypertension|Pulmonary Fibrosis,Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement,Mesenchymal Stem Cells from Wharton ÃÅs jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ÃÅs jelly,Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton¬¥s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment,Ch√≠a,Chia,Colombia,
204,205,NCT02249676,Devic's Syndrome|Devic's Neuromyelitis Optica|Devic Syndrome|Devic's Disease|Devic Disease,Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders,Autologous mesenchymal stem cells,Autologous Mesenchymal Stem Cells for the Treatment of Progressive and Refractory Neuromyelitis Optica Spectrum Disorders: an Open-label Phase 2a Proof-of-concept Study,Tianjin,Tianjin,China,January 2013
205,206,NCT03905824,Osteochondral Fracture of Talus,The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus,Allogenic stromal mesenchymal cells derived from the umbilical cord|Debridement and microfracture,"Randomized, Multicentric, Prospective, Double-blind Study: Effectiveness of Adding Allogenic Stem Cells to a Platelet-poor Plasma Scaffold After Arthroscopic Debridement and Microfractures in Patients With Osteochondral Lesions of the Talus",Santiago,Independencia,Chile,"January 15, 2019"
206,207,NCT04865107,Covid19|Acute Respiratory Distress Syndrome,Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial,UC-MSCs|Placebo,Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial,Oshawa|Ottawa|Toronto|Montr√©al,Ontario|Ontario|Ontario|Quebec,Canada|Canada|Canada|Canada,"April 27, 2021"
207,208,NCT02525432,"Brain Injuries, Traumatic|Brain Injuries, Acute|TBI (Traumatic Brain Injury)",Autologous Stem Cell Study for Adult TBI (Phase 2b),Placebo Infusion|Autologous BMMNC Infusion,A Multicenter Trial of Autologous Bone Marrow Mononuclear Cells for the Treatment of Adult Severe Traumatic Brain Injury,Houston,Texas,United States,"November 21, 2016"
208,209,NCT02846883,Abdominal Aortic Aneurysm,Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms,MSCs|MSCs|Placebo,Mesenchymal Stem Cells Induce Regulatory T Cells in Patients With Aortic Aneurysm,Indianapolis,Indiana,United States,"December 5, 2016"
209,210,NCT03682315,Sinus Floor Augmentation,Comparison of Phicogenic vs. Xenogeneic Biomaterial for Maxillary Sinus Floor Elevation,Biphasic phycogenic biomaterial|Xenograft bovine hydroxyapatite,Algae-derived Hydroxyapatite Behaviour as Bone Biomaterial in Comparison to Anorganic Bovine Bone. A Randomised Split-mouth Human Study.,Granada,,Spain,September 2016
210,211,NCT02770430,Graft vs Host Disease,Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease,mesenchymal stem cells|conventional treatment,"A Phase II, Randomized Study to Evaluate the Human Mesenchymal Stem Cells as a First-line Treatment for aGVHD in Patients Steroids Resistant.",Porto Alegre,Rio Grande do Sul,Brazil,September 2015
211,212,NCT03797963,Sinus Floor Augmentarion,Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation,PBM+ACB|ABB+ACB,Split-mouth Randomized Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation,Granada,,Spain,"January 8, 2019"
212,213,NCT05152160,Graft Vs Host Disease,Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease,Umbilical Cord Mesenchymal Stem Cell Therapy,Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease,Shenzhen,Guangdong,China,"August 1, 2021"
213,214,NCT02482194,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study,mesenchymal stem cells,Autologous Transplantation of Bone Marrow Mesenchymal Stem Cells in Patients of Spinal Cord Injury-Phase I Clinical Trial,Rawalpindi,,Pakistan,June 2013
214,215,NCT04602442,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,EXO 1 inhalation|EXO 2 inhalation|Placebo inhalation,The Extended Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Two-Sided Pneumonia,Samara,,Russian Federation,"October 1, 2020"
215,216,NCT04491240,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,EXO 1 inhalation|EXO 2 inhalation|Placebo inhalation,The Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Two-Sided Pneumonia,Samara,,Russian Federation,"July 20, 2020"
216,217,NCT02037204,Foreign-Body Reaction|Inflammation|Effusion (L) Knee|Knee Pain Swelling,IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.,Cartilage repair surgery,Instant MSC Product Accompanying Autologous Chondron Transplantation (IMPACT): Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.,Utrecht,,Netherlands,March 2013
217,218,NCT00731744,Normal Full-Term Deliveries,Generation of Dendritic Cell Precursors From Cord Blood Stem Cells,Normal full-term deliveries,Generation of Dendritic Cell Precursors From Cord Blood Stem Cells,Taipei,,Taiwan,January 2007
218,219,NCT03795649,Hemorrhage,The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty,Tranexamic Acid,The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty,Zagreb,,Croatia,"December 18, 2018"
219,220,NCT03918655,Acute Myeloid Leukemia,MIF Involvement in AML,,MIF : a New Target to Eradicate the Pre-leukemic Clone in Acute Myeloid Leukemia,Paris,,France,"July 7, 2019"
220,221,NCT02696876,"Defect of Articular Cartilage|Cartilage Injury|Osteoarthritis, Knee",Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair,Arthroscopic synovial brushing|Microfracture,Safety and Efficacy of a Novel Synovium Brushing Method for Endogenous Mesenchymal Stem Cells Mobilisation During Knee Joint Microfracture for Cartilage Repair.,Leeds,West Yorkshire,United Kingdom,January 2017
221,222,NCT03745417,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis,Umbilical cord mesenchymal stem cells,Efficacy and Safety of Expanded Umbilical Cord Mesenchymal Stem Cells On Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"August 31, 2021"
222,223,NCT04482699,Severe COVID-19 Disease,RAPA-501-Allo Therapy of COVID-19-ARDS,RAPA-501-Allo off-the-shelf Therapy of COVID-19|Placebo,Phase I/Phase II Trial of Allogeneic Hybrid TREG/Th2 Cell (RAPA-501-ALLO) Therapy for COVID-19-Related ARDS,Hackensack,New Jersey,United States,"December 30, 2020"
223,224,NCT03265613,Mesenchymal Stromal Cells|Psoriasis|Drug Toxicity|Drug Effect,Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis,adipose-derived multipotent mesenchymal stem cells,Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"September 24, 2017"
224,225,NCT03392311,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,Calcipotriol ointment|adipose-derived multipotent mesenchymal stem cells,Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"August 17, 2019"
225,226,NCT04275024,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients,Calcipotriol ointment|PSORI-CM01 Granule|adipose-derived multipotent mesenchymal stem cells,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"April 1, 2020"
226,227,NCT05086939,Knee Osteoarthritis,Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.,Autologous MSCs|Allogenic MSCs|Hyaluronic Acid,"Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis",Barcelona|Madrid|Madrid|Madrid|Murcia|M√°laga|Pamplona|Salamanca|Valladolid,,Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain,"May 26, 2021"
227,228,NCT02338271,Low Back Pain,Autologous Adipose Derived Stem Cell Therapy for Intervertebral Disc Degeneration,autologous adipose derived mesenchymal stem cell,Safety and Efficacy Study of Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration,Seongnam-si,Gyeonggi-do,"Korea, Republic of",January 2015
228,229,NCT03794622,Bone Marrow|Femoral Shaft Fracture,Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union,intramedullary nail fixation with bone marrow concentration|intramedullary nail fixation,The Effect of Autologous Bone Marrow Concentration on Femoral Shaft Fracture Union,Changhua City,Changhua,Taiwan,"June 14, 2017"
229,230,NCT03793530,Bone Marrow|Spinal Fusion,Autologous Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery,Transforaminal lumbar interbody fusion with local bone graft and intraoperative bone marrow concentration|Transforaminal lumbar interbody fusion with local bone graft,The Use of Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery: A Randomized Control Trial,Changhua City,Changhua,Taiwan,"August 1, 2017"
230,231,NCT03792594,Rotator Cuff Tear|Bone Marrow,Autologous Bone Marrow Concentration for Rotator Cuff Tear,arthroscopic repair with bone marrow concentration|arthroscopic repair,The Effect of Autologous Bone Marrow Concentration Combined With Arthroscopy for Rotator Cuff Tear,Changhua City,Changhua,Taiwan,"May 12, 2017"
231,232,NCT03787329,Avascular Necrosis of Femur|Bone Marrow,Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head,Core decompression surgery with bone marrow concentration|Core decompression surgery,The Effect of Autologous Bone Marrow Concentration Combined With Core Decompression for Avascular Necrosis of Femoral Head,Changhua City,Changhua,Taiwan,"April 14, 2017"
232,233,NCT02240823,Delayed Graft Function,Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy,adipose derived stem cells,Phase 1 Study. Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy,Odense,,Denmark,April 2014
233,234,NCT05066334,Intervertebral Disc Degeneration|Chronic Low-back Pain,Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD,Autologous BM-MSC|Sham,Intervertebral Disc Regeneration Mediated by Autologous Mesenchymal Stem/Stromal Cells Intradiscal Injection: a Phase IIB Randomized Clinical Trial - DREAM Trial,Roma,,Italy,"March 22, 2021"
234,235,NCT03103295,Bone Defects,3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects,3D-Tissue Engineered Bone Equivalent,Safety and Efficacy Study of Traumatic Bone Defects Treatment With Use of 3D Tissue Engineered Equivalent.,Kiev,,Ukraine,"November 20, 2015"
235,236,NCT04759105,Intervertebral Disc Degeneration|Chronic Low-back Pain,Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD,Autologous BM-MSC|Sham Procedure,Autologous Mesenchymal Stem/Stromal Cells for the Treatment of Workers Affected by Chronic Low Back Pain Due to Multilevel InterVErtebral Disc Degeneration: a Phase IIB Randomized Clinical Trial,Roma,,Italy,"November 17, 2020"
236,237,NCT01993368,Aggressive Periodontitis|Chronic Periodontitis,Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis,flow cytometry,Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis,Nice,,France,November 2013
237,238,NCT03369457,"Complications; Implant, Orthopedic",Analysis of the Osteogenic Potential of Multipotent Cells From Different Anatomical Regions,Isolation of multipotent cells,Analysis of the Osteogenic Potential of Multipotent Cells From Different Anatomical Regions in Hip Replacement Surgery,Milan,,Italy,"January 10, 2018"
238,239,NCT03325322,Chronic Kidney Diseases|Diabetes Mellitus|Diabetic Nephropathies,Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease,Fisetin|Placebo oral capsule,"Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease",Rochester,Minnesota,United States,"January 2, 2018"
239,240,NCT04519671,Perianal Crohn Disease|Perianal Fistula|Crohn Disease,Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,Mesenchymal Stem Cells|Placebo,A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,Cleveland,Ohio,United States,"November 19, 2020"
240,241,NCT02379442,Graft-Versus-Host Disease,Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids,MSC,A Pilot Study of Early Treatment of Acute Graft Versus Host Disease With Bone Marrow- Derived Mesenchymal Stem Cells and Corticosteroids: Correlation of Disease Severity and Response With Biomarkers,Bethesda,Maryland,United States,"February 23, 2015"
241,242,NCT05054803,Spinal Cord Injury Cervical,Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury,WJ-MSC (XCEL-UMC-BETA)|Placebo,"A Phase I/II, Randomized, Double-blind, Placebo-controlled, Parallel, 2-arms Clinical Trial to Assess the Safety and Efficacy of Intrathecal Administration of WJ-MSC in Chronic Traumatic Cervical Incomplete Spinal Cord Injury",Badalona|A Coru√±a,Barcelona,Spain|Spain,"October 13, 2021"
242,243,NCT04785027,Traditional Chinese Medicine|Drug Effect|Drug Safety|Psoriasis|Mesenchymal Stromal Cells,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis,PSORI-CM01 formula|Gu Ben Hua Yu formula|adipose-derived multipotent mesenchymal stem cells,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis: a Pilot Study for a Randomized Controlled Trial,Guangzhou,Guangdong,China,"March 17, 2021"
243,244,NCT04136743,Spinal Cord Injuries|Tendinopathy|Rotator Cuff Tears|Shoulder Pain,Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury,Lipogems|Dexamethasone,Ultrasound-Guided Treatments for Chronic Shoulder Pain in Wheelchair Users With Spinal Cord Injury: A Randomized Controlled Trial,West Orange,New Jersey,United States,"June 14, 2019"
244,245,NCT04274543,Tibial Meniscus Injuries|Knee Injuries|Knee Injuries and Disorders,Ultrasound-Guided Injections for Meniscal Injuries in Active-Duty Military,Lipogems|Normal Saline,"Use of Autologous, Micro-Fragmented Adipose Tissue to Treat Meniscal Injuries in Active Duty Military Personnel",West Orange,New Jersey,United States,"July 1, 2019"
245,246,NCT03874572,Xerostomia Due to Radiotherapy|Hyposalivation|Xerostomia|Oropharynx Cancer|Salivary Gland Diseases|Dry Mouth|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Stem Cells,Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth,Allogeneic adipose derived stem/stromal cells,A Phase I Open Label Study Evaluating the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia in Previous Oropharynx Cancer Patients,Copenhagen|Copenhagen,,Denmark|Denmark,"March 18, 2019"
246,247,NCT01051882,Amyotrophic Lateral Sclerosis,"Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.",MSC-NTF cells transplantation (IM)|MSC-NTF cells transplantation (IT),"A Phase I/II, Open Label Study to Evaluate Safety, Tolerability and Therapeutic Effects of Transplantation of Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.",Jerusalem,,Israel,June 2011
247,248,NCT04461925,COVID-19 Pneumonia,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Antibiotics|Hormones|Anticoagulant Therapy|–ûxygen therapy,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic Multipotent Mesenchymal Stem Cells of the Placenta and Umbilical Cord,Kyiv,,Ukraine,"May 2, 2020"
248,249,NCT04174547,Myelodysplastic Syndromes,An European Platform for Translational Research in Myelodysplastic Syndromes,,An Integrated European Platform to Conduct Translational Studies in Myelodysplastic Syndromes Based on the EuroBloodNet Infrastructure,Paris|Leipzig|Rozzano|Barcelona,Milan,France|Germany|Italy|Spain,"September 30, 2019"
249,250,NCT05187936,Hemophilia A|Hemophilia B|Arthropathy,Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy,,Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy,Montpellier,,France,"October 1, 2021"
250,251,NCT03876197,Radiation Toxicity|Xerostomia Due to Radiotherapy|Dry Mouth|Hyposalivation|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Long Term Adverse Effects,Mesenchymal Stem Cells for Radiation-induced Xerostomia,Autologous adipose-derived mesenchymal stem/stromal cells|Placebo,Follow-up Study of Safety and Efficacy in Subjects Who Participated in the Study of Intraglandular Mesenchymal Stem Cells in Patients With Radiation-induced Hyposalivation and Xerostomia (MESRIX),Copenhagen,,Denmark,"August 1, 2020"
251,252,NCT03555773,Crohn Disease|Perianal Fistula,Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas,Lipogems,Treatment of Complex Crohns' Perianal Fistulas by Local Injection of Autologous and Micro-fragmented Adipose Tissue,Bologna,BO,Italy,"May 11, 2016"
252,253,NCT02619734,Chronic Leg Ulcer|Sickle Cell Disease,Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease,Infusion of Autologous Bone Marrow Mononuclear Cells,Efficacy and Safety of Autologous Bone Marrow Stem Cells Infusion for Treatment of Chronic Leg Ulcer in Sickle Cell Disease Patients,,,,August 2006
253,254,NCT04883502,Bone Loss,Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs,Blood sample collection|Other biological sample collection|Surgical waste collection|Radiological examination and functional exploration,Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs,Clamart|Saint-Mand√©,,France|France,"October 29, 2021"
254,255,NCT04869761,"Chronic Kidney Diseases|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Diabetes Mellitus|Diabetic Nephropathies",Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion|Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions,Allogeneic Mesenchymal Stem Cell Therapy in Patients With Chronic Kidney Disease: A Phase I Study,Jacksonville|Rochester,Florida|Minnesota,United States|United States,"October 7, 2021"
255,256,NCT01144962,Crohn's Disease|Fistula,Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,"Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.|Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection.",Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,Leiden,Zuid Holland,Netherlands,June 2010
256,257,NCT03167138,Shoulder Pain|Shoulder Impingement Syndrome|Rotator Cuff Impingement Syndrome|Rotator Cuff Tendinitis|Rotator Cuff Syndrome of Shoulder and Allied Disorders|Spinal Cord Injuries,Micro-Fragmented Adipose Tissue (Lipogems¬Æ) Injection for Chronic Shoulder Pain in Persons With Spinal Cord Injury,Autologous micro-fragmented adipose tissue|Lipogems system,Treatment of Chronic Shoulder Pain in Persons With Spinal Cord Injury Using Injection With Autologous Micro-Fragmented Adipose Tissue Under Ultrasound Guidance,West Orange,New Jersey,United States,"July 14, 2017"
257,258,NCT01892514,Osteonecrosis,Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head,core decompression,Combined Treatment of Early and Advanced Osteonecrosis of the Femoral Head With Core Decompression and Grafting With Demineralized Bone Matrix (DBM) or Homologous Lyophilized Bone Chips (LBC) Together With Platelet-rich-fibrin (PRF) and Concentrated Bone Marrow (CBM),Bologna|Bologna|Modena,,Italy|Italy|Italy,April 2013
258,259,NCT05488093,Knee Osteoarthritis,Evaluation of Mobility in Subjects With Severe Knee Osteoarthritis Who Are to Undergo Total Knee Replacement,X-sens sensor,Evaluation of Movement and Muscular Alterations in Subjects With Severe Knee Osteoarthritis Who Are to Receive a Total Knee Replacement,Montpellier,,France,October 2022
259,260,NCT03102879,Periapical Periodontitis,Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.,Regenerative Endodontic Procedure|Conventional Root Canal Treatment,Encapsulated Mesenchymal Stem Cells for Endodontic Treatment of Permanent Teeth With Apical Lesion: a Controlled Clinical Trial.,Santiago,,Chile,"September 23, 2016"
260,261,NCT02448121,Avascular Necrosis of Bone|Sickle Cell Disease,Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease,Autologous bone marrow stem cell graft,"Treatment for Hip, Knee, Ankle and Shoulder Osteonecrosis With Autologous Mononuclear Cells Transplantation in People With Sickle Cell Disease",,,,August 2006
261,262,NCT01777646,Amyotrophic Lateral Sclerosis,"Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)","MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF","A Phase IIa, Open Label, Dose-escalating Clinical Study to Evaluate the Safety, Tolerability and Therapeutic Effects of Transplantation of Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS).",Jerusalem,,Israel,December 2012
262,263,NCT03164083,Osteoarthritis,The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis,Mesenchymal stem cell|Placebo,"Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells and Stromal Vascular Fraction Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial",Tabriz,,"Iran, Islamic Republic of","November 10, 2019"
263,264,NCT03840343,"Diabetic Kidney Disease|Diabetic Nephropathies|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Chronic Kidney Disease|Diabetic Nephropathy Type 2|Kidney Failure|Kidney Insufficiency",Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease,Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose|Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose,Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study,Rochester,Minnesota,United States,"October 23, 2019"
264,265,NCT04453111,Knee Osteoarthritis,Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis,Placenta-derived MMSCs|Bone marrow-derived MMSCs|Hyalgan 20 mg in 2 ML Prefilled Syringe,Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis,Kyiv,,Ukraine,"January 2, 2020"
265,266,NCT04919135,Frailty,Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty,Umbilical Cord Mesenchymal Stem Cells transplantation|standard frailty treatment and supplementary medication,Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation,,,,"July 1, 2021"
266,267,NCT03920397,Type 1 Diabetes Mellitus,Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus,Infusion of adipose tissue-derived stem/stromal cells and oral Cholecalciferol supplementation,Allogenic Adipose Derived Mesenchymal Stem Cells and Vitamin D Supplementation in Patients With Recent-onset Type 1 Diabetes Mellitus,Rio de Janeiro,,Brazil,"March 1, 2015"
267,268,NCT01849159,Pulmonary Emphysema,"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema",Mesenchymal stem cells|Reference therapy: 400 mL of 0.9% NaCl solution,"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema",Moscow,Moscow Region,Russian Federation,March 2014
268,269,NCT02326935,Multiple Sclerosis,Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis,Autologous adipose derived mesenchymal cells,"Proposal for a Non-randomized, Patient Sponsored, Multi-center Study Studying the Impact and Safety of the Utilization of Culture Expanded Autologous, Adipose-derived Mesenchymal Stem Cells Deployed Via Intravenous Injection for the Treatment of Multiple Sclerosis",George Town,,Cayman Islands,November 2014
269,270,NCT02145897,Critical Limb Ischemia,To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI,Autologous Stromal Vascular Fraction (SVF)|Autologous Adipose Derieved MSCs|Control,"A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intramuscular and Intravenous Administration of Autologous ADMSCS for Treatment of Critical Limb Ischemia (CLI).",Thane,Maharashtra,India,August 2014
270,271,NCT00186914,Osteodysplasia,Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation,Marrow stromal cell infusion,Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation: A Phase I Study,Memphis,Tennessee,United States,July 1999
271,272,NCT03818737,Osteoarthritis,Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES),Bone Marrow Derived MSCs|Adipose-derived MSCs|Umbilical Cord Tissue (UCT) MSCs|Corticosteroid injection,"Randomized Multicenter Phase 3 Single-blind Trial Comparing the Efficacy of Corticosteroid Control to Mesenchymal Stem Cell Preparations From Autologous Bone Marrow Concentrate (BMAC), Adipose-derived Stem Cells in the Form of Stromal Vascular Fraction (SVF), and Third-party Human Mesenchymal Stem Cells Manufactured From Umbilical Cord Tissue for the Treatment of Unilateral Knee Osteoarthritis (OA)",Gulf Breeze|Atlanta|Durham|Fargo|Sioux Falls,Florida|Georgia|North Carolina|North Dakota|South Dakota,United States|United States|United States|United States|United States,"March 28, 2019"
272,273,NCT05305833,Temporomandibular Joint Disorders|Temporomandibular Disorder|Temporomandibular Joint Osteoarthritis|Temporomandibular Joint Pain|Temporomandibular Joint Effusion,Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease,Stem Cells,Stem Cells Transplantation for Temporomandibular Joint Disease: Phase I/II Study,Kayseri,,Turkey,"October 1, 2021"
273,274,NCT04223622,Osteoarthritis,Effects of ASC Secretome on Human Osteochondral Explants,ASC secretome,Secretome From Mesenchymal Stem/Stromal Cells on Human Osteochondral Explants: Cocktail of Factors Secreted by Adipose-derived Stromal Cells (ASC) for the Treatment of Osteoarthritis and/or for Articular Regeneration,Milano,MI,Italy,"April 12, 2021"
274,275,NCT02492490,Uremia,Effect of SVF Derived MSC in DCD Renal Transplantation,SVFderived MSC transplantations|Basiliximab,Effect of Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cell in Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Randomized Controlled Trial,Fuzhou,Fujian,China,December 2014
275,276,NCT04351932,Osteo Arthritis Knee,Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis,bone marrow mesenchymal stem cells|Adipose Mesenchymal stem cells|bone marrow & adipose mesenchymal stem cells injection,Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Randomized Non Blind Controlled Clinical Trial,Guayaquil,Guayas,Ecuador,"June 7, 2020"
276,277,NCT00781872,Multiple Sclerosis,Mesenchymal Stem Cells for the Treatment of MS,Injection of autologous bone marrow derived mesenchymal stem cells,Explorative Trial to Investigate the Safety and Clinical Effects of Autologous Mesenchymal Bone Marrow Stem Cells (MSC) Following Their Intrathecal and Intravenous Administration in Severe Cases of Multiple Sclerosis (MS),,,,October 2006
277,278,NCT02957552,Pediatric Liver Transplantation,Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation,Mesenchymal Stem Cells,"Safety and Tolerance of Immunomodulating Therapy With Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation, a 24-month, Non-randomized, Open-label, Prospective, Single-center Pilot Trial",Tuebingen,,Germany,"March 10, 2017"
278,279,NCT04433104,COPD,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease,Umbilical Cord Mesenchymal Stem Cells transplantation|drug therapy according to Vietnamese MOHS procedure,"Allogeneic Human Umbilical Cord-derived Mesenchymal Stem/Stromal Cells for Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a Matched Case-control, Phase I/II Trial",H√† N·ªôi,Hanoi,Vietnam,"June 9, 2020"
279,280,NCT02442817,Schizophrenia,Linagliptin and Mesenchymal Stem Cells: A Pilot Study,Linagliptin,Linagliptin and Mesenchymal Stem Cells: A Pilot Study,Reno,Nevada,United States,"March 2, 2015"
280,281,NCT02135380,Idiopathic Pulmonary Fibrosis,Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis,Autologous Stromal Vascular Fraction (SVF)|Autologous Adipose Derived MSCs (ADMSCs)|Control,"A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intravenous Autologous Adipose Derived Adult Stem Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF).",Thane,Maharashtra,India,August 2014
281,282,NCT05280002,Osteoarthritis Knees,Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis,Adipose Tissue derived Total-Stromal-Cells (TOST),Outcomes of Single Intra-articular Injection of Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis,Dhaka,,Bangladesh,"January 1, 2018"
282,283,NCT04821479,Amyotrophic Lateral Sclerosis,Repeated Mesenchymal Stem Cell Injections in ALS,Mesenchymal stem cells (MSC),Safety and Clinical Effects of Repeated Intrathecal Injections of Autologous Mesenchymal Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS),,,,"January 1, 2016"
283,284,NCT02975960,Systemic Sclerosis,ADMSCs for the Treatment of Systemic Sclerosis,injection of autologous stromal vascular fraction,Adipose Tissue-derived Mesenchymal Stem Cells for Cell-based Therapy in the Treatment of Systemic Sclerosis,Seoul,,"Korea, Republic of","October 25, 2016"
284,285,NCT02749448,Pulmonary Disease,Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients,mesenchymal stem cell,The Effect of Autologous Adipose Mesenchymal Stem Cells in Treatment of Airway Injury in Patients Exposed to Sulfur Mustard,,,,February 2015
285,286,NCT05484856,"Osteoarthritis, Knee",Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA),Autologous adipose tissue derived stromal cells,"Prospective Single Centre, Open Label, Single Arm Clinical Study for Autologous Adipose Tissue Derived ADSCSs in Treatment of Patients With Osteoarthritis",Rudrapur,Uttarakhand,India,"May 16, 2016"
286,287,NCT01548092,Recto-vaginal Fistula,Stromal Vascular Fraction (SVF) for Treatment of Recto-vaginal Fistula,Adipose-derived stem cells without expanded,A Phase II Clinical Trial to Study the Feasibility and Safety of Stromal Vascular Derived From Adipose Tissue for the Treatment of Recto-vaginal Fistula,Madrid,,Spain,December 2011
287,288,NCT04340284,Nonunion of Fracture,Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion,autologous adipose tissue derived stromal vascular fraction (SVF),Retrospective Study to Analyze Safety and Efficacy of Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion,Rudrapur,Uttrakhand,India,"November 10, 2019"
288,289,NCT04377334,ARDS|COVID-19,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),MSC,Prospective Phase II Study: MSCs in Inflammation-Resolution Programs of SARS-CoV-2 Induced ARDS,Tuebingen,,Germany,May 2022
289,290,NCT01795950,Pulmonary Arterial Hypertension,Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH),PLX-PAD,A Phase I Safety and Pharmacodynamic Study of Intravenous Infusion of PLX-PAD Cells in Patients With PAH,Brisbane|Melbourne,Queensland,Australia|Australia,April 2013
290,291,NCT00913289,Liver Cirrhosis,Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells,adipose tissue derived stromal cells,Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells,Kanazawa,Ishikawa,Japan,February 2009
291,292,NCT02893306,Type 1 Diabetes Mellitus,MSC Administration for the Management of Type 1 Diabetic Patients,MSCs,Phase 2 Study of Intravenous Administration of Allogeneic Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus.,Santiago,Region Metropolitana,Chile,March 2012
292,293,NCT02467387,Non-Ischemic Heart Failure,A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure,Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)|Lactated Ringer's Solution,"A Phase IIa Randomized Study to Assess the Safety, Tolerability, and Preliminary Efficacy of a Single Intravenous Dose of Ischemia-tolerant Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Non-ischemic Heart Failure",Washington|Atlanta|Chicago|Stony Brook|Philadelphia,District of Columbia|Georgia|Illinois|New York|Pennsylvania,United States|United States|United States|United States|United States,"June 1, 2014"
293,294,NCT01062750,Liver Cirrhosis,Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells,adipose tissue derived stromal cells dosage,Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells,Kanazawa,Ishikawa,Japan,October 2012
294,295,NCT03939741,Chronic Kidney Diseases,SVF (Adipose Tissue Derived MSC) Based Therapy for CKD.,SVF Containg Autologous Non Expanded ADSC,Evaluation of Therapeutic Potential of Stromal Vascular Fraction (Autologous Adipose Derived Mesenchymal Stem Cell) Based Treatment for Chronic Kidney Disease,Dhaka,,Bangladesh,"April 1, 2019"
295,296,NCT03601234,Gastrointestinal Stromal Tumors,Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors,laparoscopic and endoscopic cooperative surgery|laparoscopic surgery,Application of Laparoscopy Combined With Endoscopy Surgery in the Treatment of Gastric Stromal Tumors,Xi'an,Shaanxi,China,"April 16, 2018"
296,297,NCT01709279,Ischemic Heart Failure,Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure,adipose tissue derived stromal cells dosage,,Kanazawa,Ishikawa,Japan,August 2012
297,298,NCT03887208,Skin|Scar|Cutis Laxa|Keloid|Cicatrix,Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells,Laser therapy|Autologous ADSC injection|Normal saline injection,Evaluation the Safety and Efficacy of the Treatment of Scars and Cutis Laxa Syndrome With the Use of Autologous (Fresh and Stored) Stem Cells Isolated From Adipose Tissue.,Warsaw|Warsaw|Warsaw,,Poland|Poland|Poland,"January 31, 2018"
298,299,NCT03042143,Acute Respiratory Distress Syndrome,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST),Human umbilical cord derived CD362 enriched MSCs|Placebo (Plasma-Lyte 148),"Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST): An Open Label Dose Escalation Phase 1 Trial Followed by a Randomised, Double-blind, Allocation Concealed, Placebo-controlled Trial.",Belfast,Northern Ireland,United Kingdom,"January 7, 2019"
299,300,NCT04143048,Gastrointestinal Stromal Tumor,A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules,DNA extraction of tumer tissue samples and high-throughput sequencing of small panels|DNA extraction of tumer tissue samples and blood sample and high-throughput sequencing of small panels|DNA extraction of tumer tissue samples and blood sample and high-throughput sequencing of small panels,A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules,Nanjing,Jiangsu,China,"September 1, 2019"
300,301,NCT03726255,Perianal Fistula,Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula,Mesenchymal Stem Cell injection,Retrospective Evaluation of Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula.,Madrid,,Spain,"April 1, 2014"
301,302,NCT01468064,"Stroke|Infarction, Middle Cerebral Artery",Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke,Autologous BMSCs transplantation|Autologous EPCs transplantation|IV infusion of placebo,Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Patients With Ischemic Stroke: a Randomized Controlled Trial,Guangzhou,Guangdong,China,November 2011
302,303,NCT01377870,Multiple Sclerosis,Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis,intravenous injection of mesenchymal stem cells|injection of cell free media,Effect and Side Effect of Mesenchymal Stem Cell in Multiple Sclerosis,Tehran,,"Iran, Islamic Republic of",December 2011
303,304,NCT04005989,Ischemic Heart Disease|Myocardial Ischemia|Coronary Artery Disease,Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization,Stromal Cells Injection,Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization,,,,"December 1, 2021"
304,305,NCT02622464,Dysphonia,Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction,micro injection of SVF in vocal cords,Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction,Marseille,,France,"April 7, 2016"
305,306,NCT03963544,Gastro Intestinal Stromal Tumor,Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST),oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations,Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (GIST) in a Real-life Setting: the METAGIST Observational Study,Bordeaux,,France,January 1990
306,307,NCT02763748,Gastrointestinal Stromal Tumor,the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor,Laparoscopic endoscopy combined surgery|laparoscopic and endoscopic cooperative surgery|Single-arch laparoscopic and endoscopic cooperative surgery,"the Prospective, Randomized and Comparative Clinical Study of Laparoscopic and Endoscopic Cooperative Surgery in the Treatment of Gastrointestinal Stromal Tumor",Xi'an,Shaanxi,China,June 2016
307,308,NCT05453292,Gastrointestinal Stromal Tumor (GIST),Endoscopic Ultrasound Radiofrequency Ablation for GISTs,Endoscopic ultrasound guided radiofrequency ablation,"Feasibility, Safety, and Efficacy of EUS-guided Thermal Radiofrequency Ablation in the Treatment of Gastrointestinal Stromal Tumors",Guayaquil,Guayas,Ecuador,"July 15, 2022"
308,309,NCT04614025,COVID|ARDS,Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,PLX-PAD,"A Randomized, Controlled, Multicenter, Parallel-Group Phase IIa Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Severe COVID-19",Berlin|Berlin|Bonn|K√∂ln|Afula|Haifa|Haifa|Nahariya|Tiberias,,Germany|Germany|Germany|Germany|Israel|Israel|Israel|Israel|Israel,"October 19, 2020"
309,310,NCT05523011,Psoriasis,Safety and Tolerability Study of MSC Exosome Ointment,Exosome ointment,"A Phase 1, Open-label Study to Determine Safety and Tolerability of the Topical Application of Mesenchymal Stem/Stromal Cell (MSC) Exosome Ointment to Treat Psoriasis in Healthy Volunteers",Singapore,,Singapore,"March 8, 2022"
310,311,NCT01172548,Gastrointestinal Stromal Tumors,Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST),imatinib mesylate,"A Multi-center, Single Arm, Phase II Study of Adjuvant Imatinib (Glivec¬Æ) in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor ( GIST)",Alger|Cairo|Mansoura|Ahmedabad|Pune|Mumbai|New Delhi|Amman|Beirut|Kazan|Ekaterinburg|Irkutsk|Kursk|Omsk|St. Petersburg|Riyadh|Parktown|Tainan 704|Taipei|Lin-Ko|Niaosong Township|Taichung|Taipei|Bangkok|Bangkok|Bangkok|Songkla|Tunis|Ankara,"Gujrat|Maharashtra|Tatarstan Republic|Taiwan ROC|Taiwan, ROC",Algeria|Egypt|Egypt|India|India|India|India|Jordan|Lebanon|Russian Federation|Russian Federation|Russian Federation|Russian Federation|Russian Federation|Russian Federation|Saudi Arabia|South Africa|Taiwan|Taiwan|Taiwan|Taiwan|Taiwan|Taiwan|Thailand|Thailand|Thailand|Thailand|Tunisia|Turkey,August 2008
311,312,NCT05270850,Benign Airway Stenosis|Respiratory Tract Fistula,Clinical Study on Autologous Stromal Vascular Fraction(SVF) Treatment for Refractory Benign Airway Stenosis and Respiratory Tract Fistula,Control group|SVF group,Clinical Study on Autologous Stromal Vascular Fraction(SVF) Treatment for Benign Airway Stenosis and Respiratory Tract Fistula,Guangzhou,Guangdong,China,"March 20, 2022"
312,313,NCT05385159,Scarred Vocal Folds,INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO,AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION|Placebo,INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO,Marseille,Paca,France,September 2022
313,314,NCT01874665,GIST,A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor,Ponatinib,Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor Following Failure of Prior Tyrosine Kinase Inhibitor Therapy,Boston|Boston|Portland|Philadelphia,Massachusetts|Massachusetts|Oregon|Pennsylvania,United States|United States|United States|United States,"June 5, 2013"
314,315,NCT03109301,"Neoplasms, Nerve Tissue|Neurofibromatosis 1|Heredodegenerative Disorders, Nervous System|Peripheral Nervous System Diseases",Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST),Selumetinib (AZD6244 hyd sulfate) 50mg/dose|Selumetinib (AZD6244 hyd sulfate) 25mg/m2,A Phase II Trial of the Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST),,,,"April 7, 2017"
315,316,NCT04269941,Gastric GIST,Prognostic Factors Affecting Survival of Gastric GIST,total or subtotal gastrectomy,Clinicopathological Characteristics and Prognostic Factors of Gastrointestinal Stromal Tumors Located in the Stomach in Tunisian Patients,,,,"January 1, 2000"
316,317,NCT01557543,Heart Disease|Ischemic Heart Disease|Coronary Artery Disease|Coronary Artery Disease (CAD),Stem Cell Injection to Treat Heart Damage During Open Heart Surgery,Cell Therapy,Preliminary Assessment of Direct Intra-Myocardial Injection of Autologous Bone Marrow-derived Stromal Cells on Patients Undergoing Revascularization for CAD With Depressed Left Ventricular Function,Bethesda|Bethesda,Maryland|Maryland,United States|United States,"February 29, 2012"
317,318,NCT04389450,COVID|ARDS,"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",PLX-PAD|Placebo,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of Severe COVID-19",Irvine|Los Angeles|Sacramento|Jacksonville|Augusta|Macon|Jackson|Camden|Teaneck|New York|New York|New York|Philadelphia,California|California|California|Florida|Georgia|Georgia|Mississippi|New Jersey|New Jersey|New York|New York|New York|Pennsylvania,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States,"October 1, 2020"
318,319,NCT05081921,Osteoarthritis of Knee,Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases,MesoCellA-Ortho administration|HA administration,"A Randomized, Double Blind, Two Arms, Controlled Phase I/II Safety and Efficacy Study on MesoCellA-Ortho Tissue Engineered Product Intraarticularly Administrated in Adult Patients With Osteoarthrosis",Bieru≈Ñ,Silesia,Poland,"January 5, 2022"
319,320,NCT02492308,Living-relative Kidney Transplantation,Induction With SVF Derived MSC in Living-related Kidney Transplantation,SVF-MSC induction|Basiliximab induction,Effect of Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cell in Living-Related Kidney Transplants: A Randomized Controlled Trial,Fuzhou|Fuzhou,Fujian|Fujian,China|China,December 2014
320,321,NCT01532076,Osteoporotic Fractures,Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts,Cellularized composite graft augmentation|Acellular composite graft augmentation,Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts Versus Acellular Bone Graft Substitutes for Augmentation in the Treatment of Proximal Humeral Fractures as Model for Fractures of Osteoporotic Bone - a Prospective Randomized First in Men Proof of Principle Trial,Basel,Basel-Stadt,Switzerland,June 2012
321,322,NCT02884154,Gastrointestinal Tract|Gastrointestinal Stromal Tumor,Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors,Echotip ProCore‚ìá HD Ultrasound Biopsy Needle,,,,,August 2016
322,323,NCT04314687,Cerebral Palsy,Stem Cell and Conditioned Medium for Cerebral Palsy,Umbilical Cord Mesenchymal Stem Cells|Conditioned Medium|Standard Therapy,Allogeneic Umbilical Cord Mesenchymal Stem Cells and Conditioned Medium for Cerebral Palsy in Children,Jakarta,,Indonesia,"October 13, 2021"
323,324,NCT02064062,"Achilles Tendinitis, Right Leg|Achilles Tendinitis|Achilles Degeneration|Achilles Tendon Thickening|Tendinopathy|Achilles Tendinitis, Left Leg",Autologous Stem Cells in Achilles Tendinopathy,Autologous Mesenchymal Stem Cells,Autologous Stem Cells in Achilles Tendinopathy,London,,United Kingdom,January 2015
324,325,NCT00919958,Peripheral Artery Disease|Peripheral Vascular Disease|Critical Limb Ischemia,Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia,PLX-PAD IM injection,Phase I Study of Intramuscular (IM) Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia. PLX-PAD Are Mesenchymal-like Stromal Cells Derived From a Full Term Placenta. These Placental Adherent Stromal Cells (ASCs) Are Expanded in the Company's Proprietary PluriXTM 3D Bioreactor System. PLX Cells Are Immune Privileged and Possess Immunomodulatory Properties.,Berlin,,Germany,June 2009
325,326,NCT00951210,Peripheral Artery Disease|Peripheral Vascular Disease|Critical Limb Ischemia,Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI),PLX-PAD,Phase I Study of Intramuscular (IM) Injections of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia. PLX-PAD Are Mesenchymal-Like Stromal Cells Derived From a Full Term Placenta.,Birmingham|Durham,Alabama|North Carolina,United States|United States,August 2009
